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Abstract
In the United States, over 40 million adults suffer from a generalized anxiety disorder
(GAD), with a 67% increase in overdose-related deaths. Research substantiates the
efficacy and safety of cannabidiol (CBD) for GAD. Findings show that CBD, sourced
from industrial hemp, may reduce anxiety symptoms. However, a problem exists for
individuals deciding to subscribe to CBD’s oral administration because of the inability to
remain compliant with the regimen. The measured steps that occur when a medication is
prescribed are lacking when an individual accesses CBD independently. This quantitative
cross-sectional study was designed to examine whether social cognitive theory explained
the self-reported likelihood of CBD usage for GAD patients. The five constructs of SCT
were operationalized: knowledge, expectations, situational perception, self-efficacy, and
goal setting. The instrument was validated for face, content, and construct validity, and
internal consistency reliability was established using Cronbach’s alpha. The data
collected from the sample of 114 were analyzed using stepwise multiple regression.
There was a significant association with the likelihood of CBD usage found between
three SCT constructs, namely goal setting, self-efficacy, and situational perception (p<
0.05). The inclusion of SCT was shown to explain the likelihood of CBD use for GAD.
The fortification that results from the inclusion of SCT can enhance educational programs
used to promote using CBD for those individuals struggling with GAD, with the end goal
of influencing positive social change in the arena of public health.
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Chapter 1: Introduction to the Study
This study’s topic was focused on whether the constructs of social cognitive
theory (SCT) influence participant’s likelihood of using hemp-sourced cannabidiol (see
Bitencourt & Takahashi, 2018) for generalized anxiety disorder (GAD). Some scientific
research supports the safety and effectiveness of cannabidiol (Caraballo et al., 2020;
Cooper et al., 2017; McGuire et al., 2018; Shannon and Opila-Lehman, 2016). However,
it has become evident that complications exist regarding the various qualities of the raw
materials and the complexity in dosing the substance (Larsen & Shahinas, 2020).
McPartland and Guy (2017) concluded that individuals had a broad range of opinions and
biases regarding the act of taking cannabidiol (CBD). Some were not certain if this was
akin to using marijuana, while others were not clear if it is legal to transport CBD
interstate (Mead, 2017).
Meanwhile, public health experts Trautmann et al. (2016) assert that anxiety and
depression cost the global economy 1 trillion U.S. dollars annually. Finding a way to treat
anxiety more effectively provides a four-fold return on each US$ dollars invested
(Trautmann et al., 2016). While a body of evidence shows how safe and effective CBD is
in treating GAD, it has become abundantly evident that individuals struggle to find a
dosing schedule that relieves the ailment (Elms et al., 2019). Therefore, it was warranted
to examine these attitudes toward CBD through the framework of SCT. Such an
investigation can provide the opportunity for researchers to gain a deeper understanding
of the challenges that exist and the potential impediments that might minimize the
likelihood of taking CBD for treating GAD, thus promoting positive social change.
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Background of the Problem
In the United States, over 40 million adults suffer from GAD (Lydiard, 2000).
Chollet et al. (2013) point to the risk of chemical dependency with chronic usage of
commonly prescribed antianxiety medications such as Ativan and Xanax. Meanwhile, an
assemblage of researchers showcased CBD’s safety and effectiveness in treating GAD
(Garcia-Gutierrez et al., 2020; Tambaro & Bartolato, 2012; Zuardi et al., 2017).
However, many hesitate to subscribe to CBD’s oral administration therapeutically
because of quality concerns, costly out-of-pocket expenditures, and preconceived notions
about the substance (Iannotti et al., 2020).
Simultaneously, practitioners in the field of holistic health encourage individuals
to meet health challenges early in the disease progression as a means of minimizing
suffering, becoming a master of one’s health status, and decreasing the eventual need for
more invasive, immoderate, and cost-prohibitive treatments (Zamanzadeh et al., 2015).
Complementary and alternative health (CAM) experts conducted a study that examined
the dovetailing of preventative therapies with conventional medicine to substantially
decreasing the out-of-pocket expenditures and increasing the quality of life of the patient
(Shi & Singh, 2017) while maximizing the populace’s health. Farre and Rapley (2017)
asserted that because the healthcare system is built upon the biomedical model, many
individuals are hesitant to veer off in search of those prevention-arced therapies. Other
researchers found that preventative medicine, when compared to the biomedical model,
appears to be less regulated (Wade & Halligan, 2004).
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Statement of the Problem
Anxiety has been determined to be a normal emotional response to danger or a
potential threat (Belzung & Griebel, 2001). However, that healthy protective emotion can
become pathological if it becomes uncontrollable, permanent, or maladaptive (Sartori &
Singewald, 2019). Individuals with chronic anxiety disorders can react to situations or
objects with dread and panic (Riskind, 1997). Wagner et al. (2005) asserted that the two
centrifugal treatments for anxiety-related disorders are medications and psychotherapy.
Stein (2004) revealed that GAD surpasses major depression as a strong predictor of
various functional impairments and has become a public health issue. Engel (2012)
opined that biomedicine is influenced by how society has come to conceptualize disease
collectively. The current medical model is built around traditional health authorities and
exemplifies a lack of confidence in nonmedical health-supportive models (Engel, 2012).
Su and Li (2011) ascertained an increased thrust in CAM’s participation in the
United States, most pronounced between 2002 and 2007. Serendipitously, the
endocannabinoid system, responsible for creating biological harmony between the human
body and its environment, was discovered in the 1990s (Di Marzo et al., 2004). Tambaro
and Bartolato (2012) assert that CBD has shown to be a highly effective and extremely
desirable substance for treating anxiety disorders. However, these authors noted a gap in
the academic literature that addresses a lack of operational strategies enabling individuals
to utilize CBD effectively (Tambaro & Bartolato, 2012). An estimated 40 million adults
in America are afflicted with GAD, and only one-third of those individuals are in
treatment for this rampant mental illness (Lydiard, 2000). Recognizing the magnitude of
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this public health dilemma, I contended that there is prudence for this study to
incorporate the theoretical framework of the SCT as a mechanism to explore theorydriven attitudes relating to the self-reported likelihood of CBD as an effective treatment
for GAD.
Purpose of the Study
This quantitative study explored an individual’s self-reported likelihood of using
CBD for GAD. This exploration used SCT as a vehicle to probe into consumer’s attitudes
toward the use of CBD for GAD. The research’s relevance and uniqueness stem from the
lack of a theoretical approach coupled with the recent discovery of CBD’s capacity to be
highly therapeutic for GAD. I applied and measured five SCT constructs, a theoretical
framework created by a developmental psychologist (Bandura, 2004). For this study, the
five constructs include knowledge, expectations (including outcome expectations and
outcome expectancies), situational perception, self-efficacy in using CBD, and goal
setting. The rationale behind using the SCT is that it may help CBD users effectively
apply a specific treatment protocol while discovering their effective CBD dosage. I
sought to ascertain whether these variables will collectively contribute to a more
comprehensive understanding of an individual’s reluctance or inclination toward
incorporating CBD as a holistic-oriented solution for GAD.
Research Questions and Hypotheses
Research Question 1: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the
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application of an effective treatment protocol associated with the likelihood of CBD
usage in generalized anxiety disorder?
H01: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are not associated with the likelihood of CBD usage in
generalized anxiety disorder.
Ha1: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are associated with the likelihood of CBD usage in generalized
anxiety disorder.
Research Question 2: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the
application of an effective treatment protocol associated with the likelihood of CBD
usage in generalized anxiety disorder, while controlling for age, gender, level of
education, and generalized anxiety disorder scores?
H02: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are not associated with the likelihood of CBD usage in
generalized anxiety disorder while controlling for age, gender, level of education,
and generalized anxiety disorder scores.
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
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treatment protocol are associated with the likelihood of CBD usage in generalized
anxiety disorder while controlling for age, gender, education level, and
generalized anxiety disorder scores.
Variables in the Study
The independent variables are the five constructs of the SCT. These five constructs were
measured as a mechanism to gain valuable data regarding the self-reported likelihood of
using CBD for GAD. They are:
•

knowledge,

•

expectations (This construct examines both outcome expectations and
expectancies),

•

situational perception,

•

self-efficacy in using CBD, and

•

goal setting.

The likelihood of CBD usage is the dependent variable. The five constructs of the SCT
are the independent variables while controlling for the following covariates, including
age, gender, education level, and GAD level scores.
The Perspective of the Theoretical Framework
This study examines an individual’s ability to use CBD effectively through the
lens of the SCT. SCT posits that reciprocity transpires within a social context of the
dynamic interactions between the individual’s personal factors, behavioral and
environmental factors (Bandura, 1989). Furthermore, personal factors consist of
biological, affectual, and conceptual (Sharma, 2017). The resulting convergence can
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prompt a new behavior (Turner et al., 2011). As the health field transforms into a health
model rather than a model based on disease progression, health promotion needs to be
built upon a well-constructed goal (Bandura, 2006). The creator of the SCT, Bandura
(2018), opined that when the goal was to achieve a state of wellness, medical intervention
alone is not the most conducive in attaining the end goal, which is the state of optimal
health. Optimal health status is a loftier goal compared to merely minimizing the
presenting physical or emotional symptomatology.
Using CBD for GAD differs from the experience of being prescribed a medication
for the disorder. When one examines how a drug is prescribed and compares this ritual to
starting a CBD protocol, one can likely begin to understand why a CBD user might
become less compliant. A written prescription from one’s medical doctor provides some
built-in structuring that promotes the patient’s compliance with the prescribed medication
regimen. Firstly, a required initial visit with the physician to discuss presenting
symptomatology precipitates the prescription. Next, a follow-up visit substantiates the
need to engage in the prescribed treatment protocol. However, when a consumer
considers using CBD to treat GAD, there is a less ritualistic formality to support the
decision to take such an action (Larsen & Shahinas, 2020). Coupling the utility of SCT
with CBD usage may help fortify compliance by examining the participants’ unique
ability to negotiate the necessary behavioral change so that the individual is supported to
use CBD to manage GAD and address a meaningful gap in the current research literature.
For this research, I probed participants’ self-reported likelihood of using CBD for
GAD, beginning with applying the first construct of the SCT, which is knowledge. Here,
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this construct intends to aid in discovering the individual’s current level of understanding
of the topic of CBD and GAD. The survey questionnaire probed the respondent’s insights
and facts on these topics of focus in this study. The participant’s breadth and depth of
understanding of the facts surrounding CBD and GAD are examined in Section 1 of the
survey instrument.
Next, I examined expectations, including the outcome expectations and outcome
expectancies of those considering using CBD for GAD. As an individual is poised to
make a behavioral change, the person anticipates the outcome that might springboard
from committing to the new behavior, hence, outcome expectations. Outcome
expectancies is the value that the individual places upon the ability to perform that new
behavior (Bandura, 2013). The same source posits that this modification can result from
roleplaying, thinktanks, and discussing the advantages of the shift in behavior.
Sharma (2017) asserted the need to determine a level of understanding of the
individual’s situational perceptions. As the individual realizes that the old behavioral
style and associated thinking are no longer suiting their needs, the person must shift the
understanding of tired perceptions and interpretations of the environment and behavioral
style. Had the old beliefs and perceptions been beneficial, the individual would likely not
need this self-reflection and reassessment. The SCT construct of situational perception
often requires rectification of an individual’s distorted perceptions (Bandura, 2018)
Next in this inquiry is an examination of self-efficacy in using CBD for GAD.
This study is with the potential of heightening awareness of the behavioral confidence
that supports implementing a beneficial regimen. Bandura (2013) stated that self-efficacy
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is the belief that an individual maintains regarding creating and executing an organized
action to succeed with the desired outcome. It is noted that self-efficacy continues its
evolution throughout an individual’s lifetime by acquiring new skillsets (Edinyang,
2010). The fifth construct examines goal setting to determine how likely the individual
will experience a successful outcome when taking CBD to minimize GAD. In totality, the
inclusion of this construct of the SCT will help analyze behavior initiation to fortify the
ability to maintain a new behavior (Bandura, 2018). Following is a visual of the five SCT
constructs as they are positioned to lead the individual into incorporating the new healthsupportive habits.
Figure 1
Diagrammatic Model of SCT Constructs Leading to Desired Health Behavior

Knowledge

Expectations

Situational Perceptions

Self-efficacy in using CBD

Goal Setting

Likelihood
of
CBD
USAGE
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Nature of the Study
The nature of this study is quantitative research with a cross-sectional design. The
study design provided the opportunity to acquire a snapshot of the characteristics of the
attitudes related to CBD usage. Using a Likert scale, my goal was to determine the
participants’ ease of taking CBD and the potential impediments and challenges of doing
so, through the SCT lens. My over-arching goal was to facilitate the elucidation of the
participants’ attitudes regarding the self-reported likelihood of CBD use while examining
the subject’s measurement of the SCT’s five constructs on the Likert scale designation of
0-4. These independent variables are knowledge, expectations (including outcome
expectation and outcome expectancies), situational perception, self-efficacy in using
CBD, and goal setting toward applying an effective treatment protocol for the population
seeking to treat GAD with CBD.
Operational and Constitutive Definitions
Knowledge: This first construct in SCT. Knowledge references one’s ability to
gain insight and the propensity to learn the factual elements (Bandura, 1998). This
section assesses the individual’s understanding of CBD as a potential remedy to relieve
GAD. This construct is measured by Questions 1-10 in the survey instrument. The
scoring for this construct, consisting of 10 true or false scale items, has a range of 0
through 10.
Expectations: This section assesses the individual’s outcome expectations and
outcome expectancies regarding the CBD taking for GAD. In this study, the two
classifications of this construct: outcome expectations and outcome expectancies.

11
Outcome expectations refer to the likely outcome an individual will experience following
through with taking CBD for GAD. In contrast, outcome expectancies are representative
of the valuation placed on that expected outcome (Bandura, 2004). The construct titled
outcome expectations is measured by Questions 11-15 in the survey instrument, with a
scoring scale as follows: (0) No, (1) Probably Not, (2) Maybe, (3) Probably, and (4)
Highly Likely. The construct termed outcome expectancies is measured by Questions 1620 in the survey instrument with a scoring scale as follows: (0) Not at all Important, (1)
Not Very Important, (2) Somewhat Important, (3) Important, (4) Very Important.
Multiplication of items 11 and 16, items 12 and 17, items 13 and 18, items 14 and 19, and
items 15 and 20 (Sharma and Petosa, 2014) enabled the summation of expectations of the
likelihood of using CBD; the score range is from 0 to 80.
Situational perception: This construct describes how individuals perceive and
interpret one’s behavior and environment (Sharma, 2017). This section of the survey
assessed how one’s perception affects the ability to utilize CBD for effectively treating
GAD. This construct was measured by Questions 21-24 in the survey instrument. The
scoring scale for situational perception is with the following designations: (0) No, (1)
Probably Not, (2) Maybe, (3) Probably (4) Highly Likely, and has a range of 0 to 16.
Self-efficacy: This construct is designated to examine the confidence that an
individual must exercise (Bandura, 2006) to implement an effective protocol to take CBD
for GAD. This construct is measured by Questions 25-28 in the survey instrument. The
scoring scale for self-efficacy in using CBD has the following designations: (0) No, (1)
Probably Not, (2) Maybe, (3) Probably, (4) Highly Likely, with a scoring range of 0-16.
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Goal setting: The final construct of the SCT investigates the level of confidence
in one’s ability to pursue a new behavior (Sharma & Petosa, 2014). This construct,
measured in Questions 29-33, examined the necessary strategy that needs to be
implemented to set goals for taking CBD effectively for GAD and developing a plan on
how to reach those objectives. The scoring scale for goal setting is with the following
designations: (0) No, (1) Probably Not, (2) Maybe, (3) Probably, (4) Highly Likely, with
the scoring range between 0 to 16.
Assumptions and Limitations
While cross-sectional design can serve multiple purposes, one potential barrier for
this study is recruiting an adequate number of individuals willing to complete the survey
questions. Also, as I assessed the limitations of self-reporting, there is the recognition that
it is imperative to be keen to evaluate the level of accuracy and the potential of selfreporting bias of the data collection (Short et al., 2009). The cross-sectional analysis is
with the possibility of introducing another limitation in this study. Specifically, while the
cross-sectional design provides the opportunity to collect relevant data and make a onetime ‘snapshot’ measurement of the exposure and the outcome, a cross-sectional design
can impair a researcher’s ability to derive causality in the relationship between exposure
and outcome (Setia, 2016).
Another potential limitation is that of generalizability. Although the publicly
accessible pick-up and drop-off location that was used in recruiting participants for this
study serves individuals from all SES sectors, a high percentage of participants hail from
the northeast corner of Connecticut. This county is home to individuals in a relatively
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high SES sector compared to other parts of the state and the country. Therefore, because
this study can likely only be applicable to a narrow sector of the population, the results
might have poor generalizability. The possibility of flawed generalizability was further
analyzed in the final two chapters of this study.
Scope and Delimitations
Cross-sectional studies are inclined to biases, such as selection bias, information
bias, nonresponse bias, recall bias, and confounding (Tilahun et al., 2020). The
propensity to biases can limit a researcher’s ability to prove noteworthy trends that may
or may not be occurring. An overarching concern is the potential incomplete answers to
items on the questionnaire, which would negatively influence this study’s internal
validity. Addressing the issue of generalizability, because this study is being conducted in
a high SES location, there is a need to conduct further investigations into a cross-section
of socioeconomic regions to examine the self-reported likelihood of using CBD in
situations where the ability to make out-of-pocket expenditures assess individuals’
varying degrees of abundance.
Significance of the Study
The study’s outcome gives rise to vital insights into the self-reported likelihood of
using CBD as a remedy for GAD. CBD can tone and balance the recently discovered
endocannabinoid system (Garcia-Gutierrez et al., 2020). Hence, CBD can resolve the root
cause of symptomatology rather than merely relieving the symptoms of such (Khan et al.,
2020). Practical usage of CBD enables individuals to safely self-regulate and balance
health issues that would otherwise be left in need of being treated with more potent
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pharmaceuticals. In comparison, many of the medications commonly used to treat GAD
have a plethora of side effects such as rebound, injury to the liver and kidneys, and the
propensity of addiction (Park et al., 2015; Starcevic, 2014).
Lydiard (2000) reported that GAD has a characteristic of being remitting and
relapsing for the over 40 million adults in the United States suffering from this most
prevalent mental illness. Therefore, there is a need to find effective modalities to treat
GAD other than the commonly prescribed benzodiazepines that, with long-term
treatment, carry the risk of cognitive and psychomotor function impairment (Lydiard,
2000). Bridging the field of complementary and alternative health with biomedicine
would aid in alleviating this public health burden (Mathiesen et al., 1999). Replacing a
portion of the expected 3.8-billion-dollar market with CBD could positively influence
societal change.
Moreover, in the spirit of promoting constructive social change, the overall
beneficial impacts of applying SCT to CBD use may aid in relinquishing potential
roadblocks and assist individuals in forming a more comfortable relationship with taking
CBD for GAD. This study will apply the five theoretical constructs of the SCT to
heighten awareness of the participants’ theory-driven attitudes while examining the
respondent’s comfortability when deciding to use CBD for GAD. Furthermore, this study
aims to determine if the self-reported likelihood of CBD usage is increased through the
fortification of applying the SCT framework.
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Summary
This chapter introduced an overview of this dissertation study, which is the
probing into the participants’ theory-driven attitudes toward CBD. Moreover, from the
public health perspective, I sought to highlight the potential positive social change that
may result from examining the study subjects’ attitudes toward CBD usage for GAD.
This chapter reviewed the rationale behind the probed hypotheses through the forty-five
questions instrument presented to the recipients who chose to participate in this research.
Chapter one also covered the reasoning behind selecting the cross-sectional study design
using a quantitative methodology for the proposed data collection.
Consideration of potential assumptions and limitations was explored, including
the scope and delimitation of this application. For this inquiry, I subscribed to the
theoretical framework using SCT to explain an individual’s self-reported likelihood of
using CBD for GAD. The author will move forward to build the case incorporating the
robust literature review. The overarching goal is that the findings will further clarify how
individuals can use CBD most effectively to minimize or resolve GAD. Inevitably, the
act of gaining a greater degree of understanding of the self-reported likelihood of
effective CBD usage for GAD will contribute to positive social change.
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Chapter 2: Literature Review
GAD affects 40 million adults in the United States (Lydiard, 2000). While
treatable, only 36.9% of those afflicted are in treatment for this most common mental
illness (Collins et al., 2004). Hoge et al. (2015) affirmed that there are concrete steps that
one can take to decrease symptoms, but there is little support offered in prevention
strategies (Christensen et al., 2010). Many health and law experts uphold that the
influence of biomedicine has sanctioned a conceptualization of a sick-care system that
lacks preventative care strategies (Cloatre, 2019; Engel, 2012; Sarris et al., 2013). As a
result, the current medical model-oriented healthcare system upholds the traditionalist
health authorities’ stayed beliefs, which projects a lack of confidence to engage in a
nonmedical healthcare model (Engel, 2012). CBD has been proven to effectively treat
GAD (Garcia-Gutierrez et al., 2020). Still, there is a higher likelihood that patients learn
about CBD from friends or the internet rather than from a healthcare professional
(Corroon & Phillips, 2018).
Focusing on this dilemma might help minimize the divide between alternative and
complementary healing mechanisms and public health strategies. Su and Li (2011)
revealed a higher level of participation in these preventative-arced modalities between
2012 and 2017. And while Tambaro and Bartolato (2012) recognized CBD’s high level
of effectiveness for treating GAD, these authors also noted that a gap existed in the
operational strategy to help individuals find their effective dosage. The following
literature review points to the depth and breadth of the lack of education outside of the
current medical model in alternative and complementary options, focusing on the theory-
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driven application of SCT while examining the self-reported likelihood of CBD usage for
GAD.
For this chapter, I subscribed to Ulrich’s Periodicals directory and PRISMA for
collecting the peer-reviewed, evidence-based items used to create a full literature review.
My goal was to provide a more in-depth, evidence-based understanding of the issues
surrounding the treatment of GAD and the potential impact of applying SCT. Of the total
of 96 pieces of literature utilized for this research94 of those were from 2000 to 2020; 79
of those were between 2010 and 2020, while 53 were from 2015 to 2020. Approximately
50 other journal articles were identified and incorporated into this study because of a
crucial histrionic perspective the works offered.
This chapter provides a thorough explanation of the procedure for selecting the
academic literature. There is a clarification of the reasoning behind the implementation of
the chosen key search words. I also provide the basis of why I incorporated the five
constructs of the SCT. I then present the argument as to why the SCT framework was
appropriate and explained how this theoretical framework has the potential of
simultaneously contributing to and filling a gap in the scientific literature.
Conducting the Strategic Literature Review Search
To create a robust and relevant literature review, I first researched the peerreviewed academic journals to see if I would find an abundance of literature that
showcased the safety and efficacy of CBD. Next, to understand how CBD is most
effectively dosed, I explored how this substance modulates anxiety in the human body.
An examination of how an individual comes to purchase CBD to treat GAD followed. I
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became particularly interested in the complications that might unfold because of the
freedom of choice and the lack of structure in CBD’s dosing schedule. To meet this
challenge, I incorporated the five constructs of the SCT as a systematic mechanism to
explore CBD usage’s likelihood and how this knowledge can enable an individual to find
the most effective dosage of CBD for treating GAD. The relative newness of the topic
and the recent discovery of the endocannabinoid system in the 1990s continuously
revealed numerous gaps in even the most recent literature. To add a histrionic
perspective, I infused into review some seminal works (Bandura, 1989; Bystritsky et al.,
2012; Sarris et al., 2013; Sharma & Romas, 2012; Short et al., 2009; Smith & Hitt, 2006;
Wade & Halligan, 2004).
The following is a description of pertinent academic article topics focusing on the
safety and efficacy of CBD use. In this literature review, I place equal emphasis on GAD.
The keywords searched include CBD, cannabidiol, generalized anxiety, GAD, holistic
health, biomedicine, complementary and alternative medicine, CAM, industrial hemp,
anxiety-related disorders, generalized anxiety disorders, sleep disorders, and the
endocannabinoid system. I also focused on the pertinence of the application of the SCT.
While searching for academic journal articles on SCT, key search words include social
learning theory, Albert Bandura, theoretical framework, theoretic foundations, selfregulation, cognitive formulation, Bobo doll experiment.
The Walden University library was the primary source for the research conducted
in the databases, including SAGE Journal, ERIC, and Thoreau multi-database search
engine. Google Scholar, Research Direct, Research Gate, and MEDLINE were also
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frequently searched to create the literature review. A catalog of just under 500 related
peer-reviewed articles was generated while constructing this study’s format. While 58 of
the peer-reviewed academic journals were written between 2015-2020 (88%), 94 of the
sources were written between 2000-2020. Seventy-nine of those sources fell between the
years 2010 and 2020. The remainder of the journals were included because they
introduced a vital and relevant historical perspective.
Because GAD is the focus of this study, I conducted a multi-faceted examination
of this topic through various databases. From examining areas of specialization in
pediatrics through geriatric medicine, I sought to gain greater awareness of the
complexity of the issues that might arise from various stages of the lives of those
suffering from GAD. Gaining a deeper understanding of the mediation and regulation in
brain biochemistry from CBD and the commonly prescribed medications was a critical
step in conducting a relevant literature collection upon which to draw. Looking at CBD’s
scientific development and attitudes toward CBD from as recent as 2000 to the present
day is astounding. In total, these various perspectives lent an enriched understanding of
the complexity of GAD and CBD. My curiosity was piqued as I combed the various
modalities that remain the frontline treatments, although many questions persist regarding
the safety of those commonly prescribed treatments.
Much research was done on the use and effectiveness of CBD for GAD to
substantiate if there was prudence in conducting this study. Some of the studies revolved
around a more in-depth look at the relationship between CBD use and medical protocols
for GAD. As this study was being conducted, there was some new research surfacing
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about COVID-19 and CBD usage. Some of the research was regarding the increase in
GAD because there was a global pandemic unfolding in real-time. Serendipitously,
scientists were examining CBD as a substance that modulated the stress response without
creating the risk of lowering respiration, as is noted in some of the commonly prescribed
antianxiety medications. Some of this research incorporated MRIs into the assessment of
the brain anatomy to determine changes before and after CBD usage, as noted in the
upcoming literature review table (Li et al., 2020).
To broaden my perspective, I also explored the research that was currently being
conducted in countries other than the United States. The information of the various
studies in the international locations as well as the United States has been included in the
upcoming literature review table. In the assessment of the feasibility of using CBD for
GAD, issues of brain biochemistry imbalances (De Gregorio et al., 2019), legal issues
(Cloatre, 2019), and potential medication and herb interactions were assessed (Boparai et
al., 2017). When I felt confident to move forward with examining the ‘likelihood of
taking CBD for GAD,’ I had thus drawn the conclusion that CBD is safe and efficacious
for the treatment of GAD. With the uniqueness that each user needs to find their unique,
effective dosage, it felt prudent to examine the likelihood of taking CBD for GAD. The
most current significant studies that were of pertinence to this study are listed in the
literature review table in Table 1 below.
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Table 1
Literature Review Table of Topics Pertaining to Generalized Anxiety Disorder
Author

Methods

Peer*review

Location

Focus Area

Source

Year

1 Bauerle
2 Garcia
3 Iannotti
4 Li
5 Twenge
6 Bolsani
7 Cloatre
8 DeGregorio
9 Elms
10 Linares
11 Radoi
12 Sartori
13 Shannon
14 Baric
15Bitencourt
16 Hallion
17 Baldwin
18 Boparai
19 Kendall
20 Lee
21 Reiman
22 Jurkus
23 Shannon

Quant.
Quant.
Mixed
Mixed
Quant.
Mixed
Qual.
Quant.
Mixed
Mixed
Mixed
Quant.
Quant.
Mixed
Quant.
Qual.
Quant.
Qual.
Quant.
Quant.
Quant.
Quant.
Qual.

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

Germany
Spain
Italy
China
USA
Brazil
UK
Canada
US
Brazil
Romania
Austria
USA
Croatia
Brazil
USA
UK
India
USA
UK
USA
UK
USA

GAD/COVID
Treatments
PPARy/Reg
MRI/GAD
COVID/GAD
CBD/Corti.
Med/Law
Serotonin
PTSD/CBD
CBD/GAD
Clinic/CBD
Phar./CBD
Pediatrics
CAM/CBD
PTSD/CBD
Util./Worry
CNS/Phar.
Herb/Med.
Recept/CBD
CBD/Regul.
CBD/Opioid
CBD/Fear
CBD/Sleep

Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal
Journal

2020
2020
2020
2020
2020
2019
2019
2019
2019
2019
2019
2019
2019
2018
2018
2018
2017
2017
2017
2017
2017
2016
2016

Literature Review Overview
While all the entries in the literature review table were relevant, some are not selfexplanatory. The first five entries were published the year this dissertation was written.
With a focus on two of those entries, two of these studies (1, 5) examined CBD use for
GAD through the unfolding of the COVID-19 pandemic. Some of the works in the
literature review added fortification to the study by examining the fluctuation, positive
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influence, and effectiveness of CBD on brain biochemistry- in entries 3, 4, 8, 12, 19, and
20. While the majority of the entries were quantitative, I carefully incorporated a balance
of meta-analysis studies in entries 3, 4, 6, 9, 10, 11, and 14. To elucidate the perspective
of the patient/respondent, several qualitative studies were integrated into the literature
review, including entries 7, 16, 18, and 23. All entries were rechecked to ensure that each
journal article accessed was peer-reviewed.
Social Cognitive Theoretical Framework
The SCT is utilized to support a person’s ability to influence their actions and,
therefore, increase the likelihood of producing a particular result (Bandura, 1999). The
same source reveals that the SCT was developed in the 1960s by Albert Bandura. This
theoretical framework was initially referred to as the social learning theory (Bandura &
Walters, 1977). Bandura professed that SCT could enable subscribers to contribute
positive attributes to one’s life circumstances rather than merely being a product of such
(Smith & Hitt, 2006). Bandura (2011) asserted that SCT was rooted in an agentic
construct of a human’s ability to develop, adapt, and change. The creator of SCT posits
that behavioral change occurs within a social context as reciprocity occurs between the
individual, the individual’s behavior, and the individual’s environment (Bandura, 2006).
In an analysis of how practical the application of SCT has been in similar studies,
researchers utilized SCT as the theoretical framework for chronic health condition
interventions (Tougas et al., 2015). Another study showcased the efficacy of applying the
SCT in developing electronic health design platforms (Grace-Farfaglia, 2019). Domino et
al. (2015) scrutinized ethical behavior, client narcissism, and fraud attitudes, also
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determining SCT was highly beneficial in examining corporate accounting professionals’
attitudes and behaviors. Lin et al. (2020) explored the mediation of hyper-competition
and dysfunctional conflict in complex work environments by applying the SCT
framework. The SCT was used in a study that probed the effect of CBD on the act of
simulated public speaking and determined a high success rate (Bergamaschi et al., 2011).
Knapp et al. (2020) also utilized the SCT to understand the complex multi-lateral
composition of present-day work environments.
This study will explore the participants’ self-reported likelihood of using CBD for
GAD while subscribing to the SCT framework. The application of the first construct of
the SCT is knowledge. Here, I examined the experience the participants currently
maintain on CBD use for GAD. The second construct is pointed at gaining a deeper
understanding of the subject’s expectations, including outcome expectations and outcome
expectancies by and for the participant. The third construct of SCT is referred to as
situational perception. Here, the intention was to gain insight into the study participant’s
perception and interpretation of their behavior and environment (Sharma, 2017) that
might inhibit one from successfully embarking upon a CBD regiment to treat GAD.
Self-efficacy in using CBD, the fourth construct, allows for an examination of
CBD usage self-efficacy to be considered and assessed. This concept enables the assessor
to gain insight into the subject’s degree of behavioral confidence for implementing a
beneficial CBD protocol (Bandura, 2004). The fifth construct of the SCT is that of goal
setting. Bandura (2018) professed that the use of goal setting relates to an increase in selfmonitoring behaviors. The rationale for conducting this examination through the lens of
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the SCT is that doing so will facilitate a more in-depth understanding of the attitudes and
the self-reported likelihood of CBD use by examining the respondent’s confidence level
in using CBD as an effective holistic health modality for GAD.
Prevalence of Generalized Anxiety Disorder
Belzung and Griebel (2001) contended that anxiety is considered a normal and
healthy response to threats and dangerous circumstances. Yet this healthy emotion has
become maladaptive, pathological, and even permanent (Sartori & Singewald, 2019) for
upwards of 20% of individuals between 18-54 living in the United States (Bandelow &
Michaelis, 2015). These statistics equate to approximately 40 million adults afflicted with
GAD (Collins et al., 2004). The United States Census Bureau stressed that there was a
tripling increase in GAD in adults in May of 2020 compared to the previous year
(Twenge & Joiner, 2020).
Barlow (2000) demonstrated that certain circumstances or objects could trigger a
person to have a panic attack or overwhelming and sometimes chronic feeling of dread,
while noting that essential determinants in developmental learning and psychology aided
in understanding anxiety and related disorders. The current medical-arced health care
system proclaims that there are two primary treatments for GAD: psychotherapy and
prescription medications (Wagner et al., 2005). Meanwhile, some alternative and
complementary researchers expressed concern that treating anxiety disorders is highly
influenced by the intervention-arced healthcare system rather than implementing a
preventative care approach (Engel, 2012). This research points to limitations in treatment
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protocols that could be beneficial with the inclusion of adaptogens such as CBD to treat
GAD (Zamanzadeh et al., 2015).
Complementary and Alternative Medicine
In the United States, the medical-oriented healthcare system has become more
accepting of complementary and alternative preventative-arced and health-building
modalities (Perard et al., 2015). Zamanzadeh et al. (2015) stressed that merging a holistic
health system of care with biomedicine could improve healthcare methodologies. The
same researchers asserted that this act could prompt the creation of appropriate
preventative public health education campaigns. Pelletier (1991) built an impressive case
regarding cost-effectiveness resulting from prevention strategies with a greater focus on
health promotion rather than mere intervention-styled medication modalities.
Meanwhile, Cloatre (2019) examined the convergence of traditional healing
techniques as they abutted with biomedicine. Specifically, I explored how ancient health
modalities have become the ‘pseudo’ treatments as biomedicine and law have become
centrifugal to the current healthcare system. This health law expert (Cloatre, 2019) asserts
that- while regulatory systems are recognizing various branches of ancient healing arts,
these modalities are being operationalized on assumptions disqualifying the product
because it does not resemble the medical model treatment strategies. Niemeyer et al.
(2013) showcased those medical practitioners often consider CBD to be a feasible and
effective treatment for the patient’s GAD yet remain uncomfortable recommending an
herbal supplement. Throughout the peer-reviewed literature, there was a familiar
storyline of many individuals discovering the ease of surrendering to a written
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prescription for medication rather than embarking upon the process of experimenting
with herbals remedies, such as CBD.
Epidemiology of Generalized Anxiety Disorder
The World Health Organization’s perspective on the ramifications of anxiety
disorders is showcased in a journal article that focuses on the gravity of anxiety
disorders- revealing the cumbersome economic burden to which this nation is subjected
because of the gross underdiagnosing and undertreatment of these mental illnesses (Costa
e Silva, 1998). A group of researchers conducted a cross-sectional study of 15,704
residents to assess GAD from an epidemiological stance due to COVID-19, concluding a
spike in the GAD prevalence (Bauerle et al., 2020). Meanwhile, there was an increase in
the number of researchers resounding the safety and efficacy of CBD for inflammation,
sleep disorders, and GAD (Caraballo et al., 2020; Cooper et al., 2017; McGuire et al.,
2018; Shannon and Opila-Lehman, 2016). While examining how individuals can use
CBD most effectively for an epidemic proportion of GAD, I revisited the challenge that
exists when users are left to determine what dosage is most useful for this prevalent
health threat. Moving toward a solution to de-escalate this health impediment would be a
giant step toward alleviating considerable strain on the public health arena while positing
social change.
Reiman et al. (2017) defended that not only is CBD poised to treat the root cause
of GAD, but CBD is a safe and effective treatment that can support patients to move
away from even those highly-scrutinized opioid medications so frequently prescribed for
pain relief, sleep disorders, and GAD. Reiman et al. (2017) produced substantial evidence
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revealing that 97% of those interviewed strongly agreed/agreed that cannabis use enabled
a decrease in opiate usage, while 81% strongly agreed/agreed that cannabis provides
more pain relief than opioids. Caraballo et al. (2020) highlighted the safety, effectiveness,
and tolerability of CBD with children with a mean age of 10.5 years. Garcia-Gutierrez et
al. (2020) conducted a review to determine the potential for using CBD to treat GAD
through the lens of epidemiology. These scientists determined that CBD is a safe and
effective treatment for GAD by assessing the preclinical, clinical, epidemiological, and
human experimental studies.
Generalized Anxiety Disorder and the Standard Biomedical Treatment
Baldwin et al. (2017) confirmed that while pharmaceuticals remain the standard
medical treatment for GAD, a high percentage of patients abandon the protocol because
of the untoward side effects, including weight gain and sexual dysfunction. Bourin and
Thibaut (2013) substantiated that the standard treatment methods include cognitivebehavioral therapy and psychopharmacological protocols. These researchers elaborate
those benzodiazepines, albeit highly addictive, remain the frontline treatment for GAD.
Li et al. (2020) determined that there is recognition of underdiagnosing and undertreating
GAD, urging general practitioners to be vigilant to the possibility of such developments.
Wagner et al. (2005) defended that partaking in a regular exercise program aids the brain
in releasing endogenous cannabinoids that ease anxiousness, urging a holistic approach.
Taylor et al. (2012) identified evidence supporting the prudence in incorporating
meditation, yoga, and other prevention-arced stress management techniques when
seeking to understand links between the brain and physical symptomatology
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manifestations, including GAD. A most recent study (Klotz et al., 2020) highlighted that
self-initiated CBD usage is high; however, there is a considerable limitation on
information regarding the potential of interaction with concomitant medications. These
researchers determined that this lack of data causes many to fall back into taking the
frequently prescribed benzodiazepines to manage the symptoms of GAD (Klotz et al.,
2020).
GAD and Alternative & Complementary Medicine Treatment
In a national study examining the lack of ability to keenly assess and determine
GAD and the common comorbidity of major depressive disorder, researchers are pointing
to the need for a blending of biomedicine with complementary and alternative medicine
practices (Blanco et al., 2014). Sarris et al. (2013) paved the way for further research of
treating GAD safely and efficaciously with plant-based medications, including CBD.
This team gleaned that CBD’s regular use was effective in humans’ clinical trials for a
broad range of anxiety-related disorders. Scientists examining non-compliance issues,
Bystritsky et al. (2012), demonstrated that those participants achieving a 50% reduction
in GAD symptoms were more likely to discontinue alternative therapies after eighteen
months. This common theme is reiterated in other studies, confirming that
complementary and alternative medicine for GADs continues to showcase limitations
(Baric et al., 2018; Radoi & Cicu, 2019). These researchers pointed to non-compliance
with the CAM practice- usually falling off the protocol not long after the individual feels
the relief of the symptom of GAD and begins to forget the level of discomfort previously
associated with GAD.
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Treating Generalized Anxiety Disorder with Cannabidiol
Kendall and Yudowski (2017) highlighted the brain biochemistry disorder that
springboarded from imbalances in the endocannabinoid system and focused on the
signaling pathways of the CB1 receptor- specifically the role of modulating homeostasis
processing and synaptic plasticity. In a peer-reviewed case study, Shannon and OpilaLehman (2016) determined that CBD oil can be a safe and effective treatment even in
pediatrics- for reducing GAD and improving sleep disturbances commonly associated
with post-traumatic stress disorder. Shannon et al. (2019) conducted a large retrospective
case series examining CBD’s efficacy on generalized anxiety and sleep disorders. These
researchers discovered that the inclusion of CBD positively impacted the participants’
anxiety scores as quickly as in a 30-day response in this clinical trial, with a notable
decrease in anxiety level scores in 57 of the total 72 adult samples (79.2%). This study’s
scientists also determined that the sleep scores (66.7%) showed an immediate
improvement in 48 participants.
Seeking to determine how CBD impacted other complex mental health diagnoses,
McGuire et al. (2018) assessed CBD’s safety and efficacy in various mental health areas,
including schizophrenia. These researchers determined that CBD was well tolerated, had
a clear impact on patients, and was a promising prospect as a new adjunctive therapy.
Lee et al. (2017) demonstrated anti-anxiety effects through the regulation of emotional
processing and emotional memory in response to the use of CBD. De Gregorio et al.
(2019) substantiated that CBD reduces anxiety with repetitive treatment from the
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activation of the 7-HT1A receptor and aids in repairing faulty 5-HT transmissions in
neuropathic-based pain status.
Jurkus et al. (2016) discovered that CBD caused a reduction in learned fear by
relinquishing memory reconsolidation of the fear (Linares et al., 2019). In turn, CBD
proved efficacious in enhancing extinction- the process through which “exposure therapy
inhibits learned fear.” In this case study, Shannon and Opila-Lehman (2016) determined
that CBD oil can be a safe and effective treatment for reducing GAD and improving sleep
disturbances commonly associated with post-traumatic stress disorder. Zuardi et al.
(2017) assembled a compilation of academic journal results, all of which supported
CBD’s efficacy in treating GAD, including social anxiety, post-traumatic stress,
obsessive-compulsive, social phobia, and panic disorders.
Applying Five Constructs of SCT to Explain the Likelihood of Using CBD for
Generalized Anxiety Disorder
With the recognition of the obviousness that many individuals are without the
behavioral fortitude to maintain consistency with a CAM remedy compared to taking a
prescribed drug, I sought to fortify this research with the social cognitive theoretical
structure. Recognizing that there is inadequate research regarding the challenge of
discovering one’s effective dosage of CBD (Miller et al., 2019), this framework can serve
to unfetter this typically complex process by applying the five constructs of the social
cognitive theoretical framework. This study is designed to consider the participants’
current beliefs and behavioral styles of operating. Serendipitously, SCT can help fortify
the participants to make health-supportive changes (Rowling, 2010).
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In the 1960s, this theoretical framework was first named the social learning
theory by the creator Albert Bandura (Smith & Hitt, 2006). In 1989 this learning theory
was transformed into the SCT focused on the impact of social influence and emphasized
internal and external reinforcements (Turner et al., 2011). As extracted from the SCT,
those variables include knowledge, outcome expectations and expectancies, situational
perception, self-efficacy in using CBD, and goal setting. Each construct of SCT aids in
clarifying the participants’ strengths and weaknesses regarding the modification of a
specific behavior. The SCT has been proven to be a highly effective framework in
critically examining participants’ behavioral modification mechanisms (Bandura, 2018)
by bringing clarity to the behavior that needs support through this process of
transformation.
Potential Influence of Construct Knowledge on Likelihood of Using CBD for GAD
Each participant brings into the experience of taking CBD their unique biases,
assumptions, and level of knowledge of the substance. Behavior change is accomplished
by compiling facts on the topic in focus through informative sheets, talks, and lectures
(Sharma & Petosa, 2014). A study conducted to assess the knowledge level of herbal
medicines of undergraduate medical students determined a lack of awareness that the
potential of herb/drug interactions exists (Boparai et al., 2017). In the process of enabling
an individual to become an authority of one’s health status, employing this construct
positions a researcher to unequivocally understand if further training is necessary and
precisely where to pinpoint an educational initiative. This process of gaining a clear
understanding of the participants’ knowledge of CBD could curtail the possibility of
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omitting key details (Turner et al., 2011), which might disable the individual from finding
the effective dosage of CBD for the treatment of GAD.
The Role of Outcome Expectations/Expectancies When Considering CBD for GAD
The purpose of this construct of the SCT was to aid the participant in examining
the expected result of using CBD for GAD. While each contributor enters into the
process of taking CBD with different preconceived outcomes, examining this construct
alerts the researcher to the anticipated consequence, or expectation, that might result from
engaging in the behavioral change process (Bandura, 2018). The outcome expectancy
construct emphasizes the value that the human subject places on the likely outcome that
springboards from the act of making the given behavioral change (Sharma, 2017). This
information will help a researcher gain a deeper understanding of how driven the
participant will likely be while considering CBD for GAD. In comparison, the
modification of outcome expectations evolves by discussing the behavioral change
benefits, while outcome expectancies develop by discussing the value placed upon the
anticipated behavioral adaptations.
The Rationale for Situational Perception When Considering CBD for GAD
There is prudence in gaining knowledge from the survey respondent’s current
situational perceptions and interpretation of the level of awareness of the healthsupportive attitude within the context of one’s environment (Manjarres-Posada et al.,
2020). The knowledge gained by understanding an individual’s situational perceptions
can rectify the dysfunctional behavior by recognizing those current and past
misperceptions (Bandura, 2018). Through this assessment, the respondent can reposition
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their perceptions and interpretations to aid in increasing the likelihood to attain the end
goal of gaining the fortitude to follow through with a health-supportive behavioral change
(Smith & Hitt, 2006). Thus, this newly developed skillset can increase the likelihood of
acquiring a health-supportive habitual behavior.
Self-Efficacy in Likelihood of Using CBD for Generalized Anxiety Disorder
Having confidence in one’s capacity to follow through with new behavior is an
element that all change-makers need to contend with while making an essential healthsupportive transition. Researchers Shamizadeh et al. (2019) tested behavioral confidence
in a study focusing on prediabetes patients. These scientists concluded that there was
indeed value derived from applying the SCT- as it assisted those in making lifestyle
changes that guided the participants in modifying the individual’s familial propensity to
prediabetes. The role of the theoretical framework in this study was to gain a higher level
of insight into the subject’s belief in their ability to pursue the new behavior of taking
CBD for minimizing or resolving their GAD.
Gaining a more in-depth understanding of what practical steps (Turner et al.,
2011) need to be taken to turn the intention of taking CBD into a health-supportive
behavior is the pinnacle goal. Bandura (1989), the creator of this theoretical framework,
proclaimed that there is value in understanding how an individual can execute a course of
action to enable a health-supportive change. Providing an individual with specific
behavioral change techniques can aid in increasing confidence in implementing a
holistic-arced treatment rather than a mainstream medical treatment protocol (Turner et
al., 2011).
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Examining Goal Setting as One Seeks to Treat GAD with Cannabidiol
Through the SCT application, one must notice the interaction within and between
the five constructs. Also, Bandura (2011) educated that there is reciprocity between the
individual, the person’s environment, and the subject’s response to stimuli through
achieving goals. This over-arching theme of the act of goal setting aids the participant to
glean a snapshot of precisely where to focus on those necessary shifts in awareness to
enable the health-supportive behavioral change (Manjarres-Posada et al., 2020). Sharma
(2017) defended that modification of self-control is constitutionalized by setting a goal,
monitoring one’s behavior, and the inclusion of an award system for the reinforcement of
accomplishing the given health-supportive change. Because taking CBD for GAD
necessitates that every individual discovers one’s effective dosage, goal setting is a
critical construct of the SCT when seeking to heighten compliance and increase the
likelihood of using CBD successfully.
Summary
Through the lens of public health, it has become obvious that GAD is made even
more complicated because of the lack of effective treatment strategies other than the
commonly prescribed pharmaceuticals (Bolsoni et al., 2019; Bourin & Thibaut, 2013). A
band of researchers has CBD clearly in focus as a safe and efficacious treatment for not
only the management of GAD the is scientific evidence showcasing that CBD can even
eliminate GAD (Caraballo et al., 2020; Cooper et al., 2017; McGuire et al., 2018;
Shannon and Opila-Lehman, 2016). Hallion et al. (2018) professed that GAD is an
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affliction characterized by agitation and worry- and can be debilitating without
appropriate monitoring and applying suitable treatment strategies.
In this chapter, I critically examined the most current research, measurements, and
published data that showcased this study’s focus areas. These focal areas included the
incidence and prevalence of GAD, the most common and easily accessible biomedicine
treatments, and the potential benefits and risks of each. This literature review included an
abundance of primary academic research exploring the feasibility and likelihood of using
CBD to treat GAD. This chapter showcased how the SCT can help individuals find an
effective dose of CBD for GAD while addressing a gap in the scientific literature.
Finally, incorporating the SCT served as the theoretical framework to explore the
participants’ self-reported likelihood of using CBD for GAD. Moreover, I included a
robust number of works articulated by key theorists into the section to expose’ how this
study benefited from SCT’s inclusion. Incorporating the robust literature review provided
the anchor to pivot to the research methodology- which served to elucidate how this
research was operationalized in the upcoming segments of this study.
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Chapter 3: Research Methods
Introduction
The purpose of this quantitative study was to explore the study respondent’s selfreported likelihood of the inclusion of CBD to manage or resolve GAD. The rationale for
the study design that was chosen for this study is outlined in the first section of this
chapter. The stages of the study are thoroughly defined throughout this section.
Beginning with the fortification of the SCT, the goal was to gather information from the
participants to understand the role that attitudes play in deciding to use CBD to manage
or alleviate GAD symptoms. Accessing this data was enabled by my quantitative research
questions:
Research Question 1: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the
application of an effective treatment protocol associated with the likelihood of CBD
usage in generalized anxiety disorder?
H01: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are not associated with the likelihood of CBD usage in
generalized anxiety disorder.
Ha1: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are associated with the likelihood of CBD usage in generalized
anxiety disorder.
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Research Question 2: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the
application of an effective treatment protocol associated with the likelihood of CBD sage
in generalized anxiety disorder, while controlling for age, gender, level of education, and
generalized anxiety disorder scores?
H02: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are not associated with the likelihood of CBD usage in
generalized anxiety disorder while controlling for age, gender, level of education,
and generalized anxiety disorder scores.
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are associated with the likelihood of CBD usage in generalized
anxiety disorder while controlling for age, gender, education level, and
generalized anxiety disorder scores.
The uniqueness of this study stemmed from the prior absence of applying the SCT
in CBD usage. Furthermore, SCT probed into the respondent’s attitudes regarding finding
the most effective CBD dosage to minimize GAD symptoms. The research’s relevance
stemmed from the innovative pairing of the under-researched issue of the complexity of
finding one’s effective dosage of CBD with the SCT’s theoretical framework. I gauged
the participants’ likelihood of CBD usage by measuring the five constructs of SCT,
including knowledge, expectations, situational perceptions, self-efficacy in using CBD,
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and goal setting. The over-arching goal was to find a more concrete way to teach
individuals how to adhere to a CBD regiment in a manner that is most specific and
effective for GAD. Inclusively, the SCT constructs increased awareness of the
participants’ inclination or reluctance to take CBD as an effective nonmedical remedy to
treat GAD.
To enrich the understanding of the basis of this study, I am seeking to inform the
reader of each of the chosen methodology elements employed to enable in-depth research
and data collection. As a mechanism of increasing awareness of individuals’ attitudes
toward CBD usage, I am covering the rationale for examining an individual’s selfreported likelihood of using CBD while applying the SCT. I provide a thorough
explanation of how I am operationalizing the variables as a mechanism to gain a more
robust understanding of the participants’ self-reported likelihood of using CBD to
minimize acute or chronic anxiety. In this chapter, I cover the objective of the data
analysis, as well as data management. I am thoroughly addressing the instrumentation
and operationalization of constructs. I am presenting the steps taken to increase validity,
reliability, and other potential breaches of trustworthiness.
The Rationale for Research Methodology and Study Design
The study was designed to probe the survey respondent’s likelihood of using CBD
to treat GAD. This cross-sectional study design was suitable for this study to answer the
research questions while testing the hypotheses. A cross-sectional study design is apropos
when a researcher seeks to gain data from the sample at a single point in time (Creswell
& Creswell, 2013). The same source proclaims that the cross-sectional design aids in
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deciphering the population’s characteristics such as age, geographical location, and other
demographical details. In this study, the independent variables were the five constructs of
the SCT. With the consideration of time constraints, this study had neither prospective
nor experimental study attributes. I surveyed the respondents over a predetermined
timeframe, which also fulfilled one benchmark for the rationale of choosing a crosssectional research study design. This observational study design allowed for investigating
the one-time measurement of both the exposure and outcome simultaneously (Setia,
2016). In an observational study design, it is not a researcher’s role to influence or alter
participants’ exposure (Barnett et al., 2012), as was the case in this research.
Independent Variables
In this study, the five constructs of the SCT were the independent variables. In
establishing cause and effect through the research methodology, I sought to determine the
independent variables that would showcase the impact of the respondent’s self-reported
likelihood of using CBD in this study. Gaskin and Happell (2014) stressed that the
independent variables are centrifugal to analytical health research. These statistical
experts defended that the independent variable is the cause; the independent variables
have stability and are not affected by other variables (Dennis et al., 2000; Gaskin &
Happell, 2014; Giuliano & Polanowicz, 2008). The independent variables reference the
study’s condition under examination (Creswell & Creswell, 2013). These researchers
asserted that a theory is an interlinked group of constructs, otherwise known as
quantitative research variables. Creswell and Creswell (2013) also proclaimed that these
constructs are then composed into hypotheses to choreograph the relationship
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encompassed by the variables. The concept of a theoretical rationale is an addendum to
this definition, which explained the prediction or expectation of the discovered
relationship (Labovitz & Hagedorn, 1971).
This study examined the participants’ attitudes surrounding the decision and
follow-through of taking CBD for GAD while maintaining focus on measuring SCT
constructs employed in this study. These constructs consisted of knowledge, expectations
(including outcome expectations, outcome expectancies), situational perception, selfefficacy in using CBD, and goal setting. These independent variables were analyzed by
examining the study respondent’s process of managing a CBD treatment protocol to
minimize GAD. This study aimed to elucidate the data derived from the survey’s
answers, utilizing a numeric Likert measurement with designations on a scale of 0-4. This
measurement helped gather data enabling a higher level of understanding of the
participants’ attitudes regarding the ease, challenges, and potential impediments of
finding one’s effective dosage of CBD to manage anxiety symptomatology.
The Dependent Variable in this Study
The dependent variable in this study was the likelihood of using CBD for GAD.
The expectation is that the dependent variable would be influenced by the independent
variable or variables (Aschengrau & Seage, 2014). The same source asserted that the
‘presumed effect’ of the research study is the dependent variable. In this study, I sought
to determine the effect of the SCT’s five constructs on the respondent’s self-reported
likelihood of CBD for GAD.
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Methodology
Study Population
The population that comprised the sample for this study was inclusive of
individuals living in a community in the northeast corner of the state in Connecticut,
including, but not limited to, Cos Cob, Darien, Easton, Georgetown, Greenwich, New
Canaan, Norwalk, Redding, Ridgefield, Rowayton, Springdale, Stamford, Weston,
Westport, and Wilton. The New York communities were Armonk, Bedford Hills,
Lewisboro, Mount Kisco, Pound Ridge, and South Salem. Individuals from the said
communities frequent the publicly accessible holistic health center, which served as the
survey distribution and drop-off location. Individuals frequent this nutrition center from
throughout the state, as well as the abutting states of New York; Rhode Island to the east,
and Massachusetts to the north.
Some of the towns that comprised this study population were within Fairfield
County, Connecticut, with a population total of 943,332 (United States Census Bureau,
2019) and a median income of $92,969 between 2014 through 2018. Of those living in
Fairfield County, 89.9% had a high school diploma or higher, and 47.4% held a
bachelor’s degree. The same source revealed that those in the study population residing in
New York hailed from Westchester County constituted a total population of 949,218,
with a median income of $92,758 (United States Census Bureau, 2019). Those living in
Westchester County with a high school diploma or higher comprised 87.8%, while those
holding a bachelor’s degree or higher included 48.2% (United States Census Bureau,
2019).
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Recruitment Procedure, Ease of Participation, and Data Collection
I collected the data from surveys distributed to approximately 120 individuals
suffering from GAD through a publicly accessible holistic health center/natural food
store. While some of this sample was self-referred, others were introduced through
various practitioners, including psychiatrists, psychologists, psychotherapists, sleepdisorder clinics, immunologists, general practitioners, rheumatologists, oncologists, and
advanced practical registered nurses. Additionally, a wide array of holistic-arced
practitioners also referred individuals to this highly frequented public access
complementary and alternative health center, including chiropractors, nutritionists,
acupuncturists, reiki therapists, yoga instructors, public health experts, fitness trainers,
and physical therapists. These practitioners’ common goal was to help the patients treat a
wide range of maladies, including anxiety-related disorders. Moreover, this
complementary and alternative health center offers a wide array of health-supportive
organic foods, nutraceuticals, homeopathic remedies, and herbal supplements, including
CBD products.
I aimed to create a collaborative study involving scientific research with
community members (Akamani & Hall, 2015). In this study, I sought to gain a more indepth understanding of those community participants- gaining valuable data regarding the
potential complexities of using CBD as a mechanism to treat GAD. To this end, email
blasts announced the community members’ opportunity to participate in this research. In
addition, community announcement board postings in the northeast corner of CT, and
announcements through social media, including Instagram and Facebook, also raised
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awareness of the opportunity to participate in this study. Social media influencers
broadened the reach of potential participants struggling with generalized anxiety to
various mental health platforms, mother’s groups, men’s clubs, and Parent/Teacher
Associations consisting of individuals residing in New Canaan and surrounding towns
throughout Connecticut and New York.
The study survey packets were publicly accessible to potential participants in
plain, unmarked envelopes. The designated pickup and drop-off hub, located in the center
of a village, is easily and equally accessible by pedestrians and those driving. For ease of
accessibility, a curbside pickup was available as a mechanism to mitigate any obstacles or
barriers to participating in this study. The completed surveys were returned directly to me
and then placed into a sealed collection box- to guarantee anonymity and relinquish
potential privacy concerns.
I discussed the debriefing and exit strategy at the point of drop-off of the survey
questionnaire to each participant in this study. One critical step in the process of
participating in this study- the act of taking the survey in and of itself expressed informed
consent on behalf of the participant (See Informed Consent Form in Appendix A). After
the participant returned the completed packet, I placed the complete survey questionnaire
directly into the lockbox owned solely by myself, Margaret Wenzel. Further deidentification: the participants’ questionnaire packets were assigned a numeric
referencing code to further maintain anonymity.
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Ethics
To ensure adherence to the standards set forth by Walden University, I exercised a
significant level of consideration and reflection to what seemed to be even the most
insignificant of details. For collecting new data, the Walden University Research Ethics
Approval Checklist was used as a primary guideline. The forty questions regarding the
ethical standards employed for this study were thoroughly examined and answered. This
proposal and research design were built so that each answer to those forty questions on
the Research Ethics Approval Checklist was YES while being as self-critical and
objective as could be. Simultaneously, these standards prepared me for the Institutional
Review Board’s pending review following this proposal’s approval (Walden University,
n.d.). One of the panel experts who aided in the instrument’s creation and final approval
has a health law background. Having an individual on the panel with expertise in this area
offered a keen eye for ethical details throughout the medical disclaimer, informed
consent, and the instrument’s vocabulary.
Instrument
Since I was planning to collect data in my workplace, one of the panel experts
recommended having a preemptive consultation with the Institutional Review Board
(Walden University, Center for Research Quality, n.d.). As a result of this meeting and
then reviewing the available guidelines regarding data collection at one’s workplace, it
was recommended that the recruitment, data collection, informed consent would be
achieved in a manner that hinders a researcher from knowing which individuals
participated and those who chose not to participate (Walden University, 2020). First, the
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preferred recruitment methods through collecting data and gaining informed consent were
thoroughly considered and addressed. Next, these methods were combed and validated by
a panel of seven experts. All reviewers can access a copy of the Informed Consent deidentification process in Appendix A for complete details of this process.
Operationalization of the Five Constructs
This first construct in SCT, knowledge- referenced one’s ability to gain insight
and their propensity to learn the factual elements (Bandura, 1998). This section probed
the study participant’s prior understanding of CBD. The knowledge section also assessed
the individual’s understanding of CBD as a potential remedy to relieve GAD. The scoring
for the construct knowledge consisted of 10 true or false scale items and had a scoring
range of 0 through 9.
The second construct assessed the individual’s expectations and expectancies
regarding the taking of CBD for GAD. In this study, the two classifications of this
construct: Outcome expectations referred to the likely outcome an individual will
experience while following through with taking CBD for GAD. In contrast, outcome
expectancies were representative of the valuation placed on that expected outcome
(Bandura, 2004). The scoring scale for outcome expectations consisted of items 10-14
and was with a scoring range as follows: No (0), probably not (1), maybe (2), probably
(3), highly likely (4).
The scoring scale for outcome expectancies consisted of items 15-19 and was with
a scoring as follows: Not at all important (0), not very important (1), somewhat important
(2), important (3), very important (4). The multiplication of items 10 and 15, items 11
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and 16, items 12 and 17, items 13 and 18, and articles 14 and 19 (Sharma & Petosa,
2014) enabled the summation of expectations regarding the likelihood of CBD usage; the
scoring range was from 0 to 80. The third construct described how individuals perceived
and interpreted one’s behavior and the environment (Sharma, 2017). This section
assessed how one’s situational perception affected the ability to effectively utilize CBD
for treating GAD. The scoring scale for situational perception consisted of items 20-23
and was with the following designations: No (0), probably not (1), maybe (2), probably
(2), highly likely (4), and had a range of 0 to 16.
The fourth construct was designated to examine the confidence an individual must
exercise (Bandura, 2006) to implement an effective protocol for taking CBD for GAD.
The scoring scale for self-efficacy in using CBD consisted of items 24-27 and was with
the following designations: No (0), probably not (1), maybe (2), probably (3), highly
likely (4), and was with a scoring range of 0 to 16. The fifth construct of the SCT
investigated the level of confidence in one’s ability to pursue a new behavior (Bandura,
2018). This construct examined the necessary steps that needed to be taken to set goals
for taking CBD effectively for GAD and developing a plan on how to reach those
objectives. The scoring scale for the construct of goal setting consisted of items 28-31
and was with the following designations: No (0), probably not (1), maybe (2), probably
(3), highly likely (4), and was with a scoring range of 0 to 16. The scoring for the
dependent variable- Likelihood of CBD Usage (Item 32) had the following designations:
Not at all (0), probably not (1), maybe (2), probably (3), and highly likely (4), and was
with a scoring range of 0 to 4.
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Sample Size Calculation
As this study was poised to investigate the self-reported likelihood of taking CBD
for GAD, there were five predictor variables: knowledge, outcome expectations and
expectancies, situational perception, self-efficacy in using CBD, and goal setting. The
effect size = 0.15 (medium), the alpha level = 0.05, the power = 0.80, and number of
predictors 9 (five constructs of SCT and 4 covariates). Using these indices in G*Power, it
was determined that a sample size of 114 participants would confer a medium effect size.
I determined the sample size by creating a scenario whereby numerous observations were
provided to replicate data opportunities in the statistical sample (Stamatopoulos, 2019),
utilizing G*Power 3.1.9.7 statistical power analysis. However, because there was a
relatively low number of respondents (114), this left some concern that an analysis of
subgroupings would perhaps not have the power to be applied to a more extensive
population. Further coverage of this potential issue will be conducted in chapter five.
Data Analysis Plan
For this data analysis, I sought to determine the independent variables’ ability to
predict the dependent variable- the likelihood of using CBD for GAD while controlling
for age, gender, education level, and GAD scores. The primary objective of this crosssectional study was to investigate the associations between the variables while seeking to
determine the moderating effects of age, gender, level of education of the participants,
and GAD scores. To gather this data for analysis, I had chosen the following sequence of
data collection arrangements in my data analysis plan. In order of execution, Cronbach’s
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Alpha was run in SPSS 25 for the purpose of assuring internal consistency reliability of
the purpose-built survey questionnaire instrument.
Included in the data analysis plan, the descriptive statistics of the independent
variables, including knowledge, outcome expectations and expectancies, situational
perception, self-efficacy, goal setting, and the dependent variable likelihood of CBD
usage, enables the organization and summarization of the characteristics in the data set.
As a clarifying visual aid, a boxplot of the five constructs allowed for viewers to quickly
deduce if there was skewness, dispersion, and potential outliers in the data. There was
prudence in including a Pearson correlation coefficient test as a mechanism to measure
the strength of the association between the variables.
I used a stepwise regression analysis in SPSS Version 25 (IBM, 2019). The
stepwise multiple regression statistical test is in the F tests family, a fixed model,
specifically with the designation of R2 deviation from zero. The utility of the Adjusted RSquared statistical test enabled the adjustment of the statistics dependent upon the
number of the independent variables in this study (Sharma & Petosa, 2014). As this study
investigated the likelihood of taking CBD for GAD, there were five predictor variables:
Knowledge, outcome expectations and expectancies, situational perception, self-efficacy
in using CBD, and goal setting.
Management of Data
For this study, I collected and utilized primary data. I created the instrument
precisely and purposefully for this research data collection. Much attention was paid to
keeping the survey questionnaire simple, direct, precise, and unfettered (Presser et al.,
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2004). Briggs (2015) urged that it is vitally important to take steps to avoid common
survey issues such as leading questions or another potential bias-arced verbiage. I
analyzed the independent predictor variables- the five constructs of SCT, including
knowledge, expectations, situational perception, self-efficacy in using CBD, goal setting,
and the dependent variable, likelihood of CBD usage. The demographics data was
examined in the Pearson product-moment correlation statistical test, with the remaining
baseline variables utilized to identify the potential influence of confounding components.
In Section 1 of the survey instrument: Knowledge of CBD and GAD, the choices
for the respondents were ‘true,’ ‘false,’ and ‘don’t know.’ As coded in SPSS, if the
respondent chose the answer of ‘true,’ the individual received a “1.” If the said
respondent determined the solution of ‘false,’ or ‘don’t know,’ they received a “0” as
coded in SPSS. This measurement system prompted the respondent to make a definitive
response, a technique that researchers discovered helps avoid ambiguity (Liedtka et al.,
2008). In Sections 2, 3, 4, and 5, a Likert scale was utilized whereby these ordinal
variables had inherent ordering. In the final section of the instrument, Demographics:
While Question 34- What is your age was a continuous variable, Questions 35-39 were
the nominal and ordinal variety of variables.
Validity and Reliability
Habig (2020) stressed that the utmost advantage of a cross-sectional study was to
examine the absence or presence of outcome or exposure at a given time point. While all
research is subject to internal and external threats to validity, great care was taken, and
critical thinking was applied to minimize the potential of such threats. The population
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was well represented by randomizing the wide variety (cross-section) of individuals who
accessed this research survey. From the conception of this topic, I applied critical
thinking to develop the research question. Its complexity provided limitations of the
probability of an alternative explanation that might account for the findings (Ditterich,
2010). This same academic source opines that it is vital that researchers strategically
utilize statistical controls to reduce threats to internal validity.
A seven-person panel of experts agreed upon the instrument’s face and content
validity with an end goal of minimizing threats to internal validity. This consultant board
of experts was a thoughtfully comprised group of adept professionals. All panelists have
areas of expertise in mental health, public health, linguistics, and pharmacology (See
Appendix B). I tested the reliability by examining the standard deviation and the mean
similarities between groups, a method that has been deliberated by other scientists (Nijjar
& Khan, 2017).
Internal validity for each of the subscales was conducted to ensure the reliability
of the instrument. Measuring the internal consistency was achieved through the
application of Cronbach’s alpha. This process provided clarity regarding whether the
questions would produce a reliable measurement of the variables (Tavakol & Dennick,
2011). This testing procedure was accomplished through the SPSS statistical process
platform. Cronbach’s alpha provided a summary measuring internal consistency
reliability by calculating the degree of intercorrelation among all the items that have been
designed for measuring a construct in the study instrument (Santesson et al., 2020;
Sharma & Petosa, 2014). Eigenvalue over 1.0 and factor loadings over 0.48 (after
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doubling the critical value of 0.24 for a sample size of 114) for each item were the criteria
used to confirm the factor structure (Sharma & Petosa, 2014; Stevens, 1996).
Summary
I conducted this research using the cross-sectional design methodology. This
study targeted the population of those individuals living in or around the northeast corner
of Connecticut. Specifically, I focused on those individuals in pursuit of exploring the use
of CBD for GAD. For randomness, this research opportunity was accessible to all
individuals, and there was no systematic sampling process. G*Power (Faul et al., 2007)
aided in determining that 114 respondents were needed to participate in this study.
Attention to any potential ethical issues was centrifugal to this chapter.
I created the questionnaire instrument explicitly for this study. The face and
content validity process had been achieved through an examination by a panel of seven
health and academic content experts. This chapter included information regarding the
utilization of Cronbach’s Alpha to test the survey instrument’s psychometric soundness.
This chapter also covered the statistical tests, including the Adjusted R-squared that I ran
in SPSS Version 25, to analyze the survey data collection. Cronbach’s alpha was
conducted to measure the internal consistency reliability of the instrument.
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Chapter 4: Results
For this study, I sought to investigate the ability of the five SCT constructs to
predict the self-reported likelihood of effectively using CBD for GAD. Specifically, the
purposefully devised survey questionnaire was with the aim to evaluate the constructs of
SCT: knowledge, outcome expectations and expectancies, situational perception, selfefficacy, and goal setting. While this study intended to survey individuals with GAD,
some participants were self-referred. Others were referred to New Canaan Healthfare
LLC through a wide array of holistic-arced practitioners, including chiropractors,
nutritionists, acupuncturists, reiki therapists, yoga instructors, public health experts,
fitness trainers, and physical therapists. These practitioners’ common goal was to help
patients treat a wide range of maladies, including anxiety-related disorders.
The location where this study was conducted is a complementary and alternative
health center that offers a wide array of health-supportive organic foods, nutraceuticals,
homeopathic remedies, and herbal supplements, including CBD. In a community with a
high percentage of individuals holding at least a bachelor’s degree, many shoppers have a
keen interest in the importance of preventative healthcare. Because of this community’s
high socioeconomic status, most shoppers have the disposable income to comfortably pay
out-of-pocket for products that might be considered luxury items to those in a lower SES
community.
This chapter covers the data collection process, the analysis of the data through
IBM SPSS Version 25, and the study results. This results section includes charts and
diagrammed visuals to aid in comprehending the outcome of this examination. The
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results of this data analysis are organized into three sections. The first section describes
how the variables were operationalized using the SCT constructs. Following, also in the
first section, is an explanation of the data collection methods. The information in the
second section describes the operationalization of the constructs in answering the
research questions. As described in the third section, I implemented a stepwise regression
analysis to evaluate the research questions.
Data Collection
The data collection began after receiving Walden University’s IRB approval
number for the proposal: 04-27-21-0742839, which expires on April 26, 2022. Strict
adherence to the guidelines and recommendations of the IRB at Walden University was
followed through recruitment and collecting the data. The respondents simultaneously
filled out a GAD-7 self-administered seven-item instrument to measure the severity of
anxiety symptoms as part of the questionnaire. The GAD-7 is a self-reporting survey
questionnaire that takes under 10 minutes to complete. In 2006, the GAD-7 self-reporting
assessment tool was developed by three colleagues: Dr. Kurt Kroenke, Dr. Robert
Spitzer, and Dr. Janet Williams, which was backed by a grant through Pfizer. For this
study, this assessment was administered in paper and pencil form. The GAD-7 is also
available in online formatting. Permission is not required to incorporate the GAD-7
assessment into an academic study. In a peer-reviewed journal article, A brief measure
for assessing generalized anxiety disorder: the GAD-7, the conclusion illuminated that
good agreement existed between the interviewer-administered and the self-reported
version of the GAD-7 assessment tool (Spitzer et al., 2006).

54
This data collection occurred between May 1, 2021, and June 15, 2021. To each
participant, I explained that this study aimed to examine the likelihood of CBD use for
GAD through the lens of SCT. The survey questionnaire included a section whereby I
assured the participants that their anonymity would be maintained. I also clarified to each
participant that their consent was implied by filling out the survey, leaving no reason to
include any personally identifying information on the questionnaire. One hundred thirty
participants showed interest in completing the survey, were eligible, and collected the
questionnaire in person. Some participants filled out the survey in privacy in a quiet
section of the approved facility from where the study took place. In contrast, others
brought the questionnaire home to complete the survey. Of those hard copy surveys
distributed, 114 surveys were executed and returned within a time frame of 6 weeks to a
holistic health facility easily accessible in the heart of a high SES pedestrian-friendly
community in Fairfield County, Connecticut. I then placed each anonymous survey into
the pile of other completed surveys in a designated lockbox maintained solely by me.
This data collection process was explained to and witnessed by each participant.
A small token of appreciation was then given directly to the study participant after the
survey was returned- to highlight and substantiate the importance of effectuating the act
of contributing to social change. In the spirit of minimizing any potential coercion or
response bias, there was no mention of any form of reward offered before the point in
time when the respondent’s questionnaire was completed and returned. There were no
discrepancies in the data collection from the plan presented in Chapter 3 of the proposal.
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A total of 114 participants completed the survey questionnaire. All the surveys were
complete, and there were no deletions.
Research Question 1: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the
application of an effective treatment protocol associated with the likelihood of CBD
usage in generalized anxiety disorder?
H01: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are not associated with the likelihood of CBD usage in
generalized anxiety disorder.
Ha1: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are associated with the likelihood of CBD usage in generalized
anxiety disorder.
Research Question 2: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the
application of an effective treatment protocol associated with the likelihood of CBD
usage in generalized anxiety disorder, while controlling for age, gender, level of
education, and generalized anxiety disorder scores?
H02: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are not associated with the likelihood of CBD usage in

56
generalized anxiety disorder while controlling for age, gender, level of education,
and generalized anxiety disorder scores.
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are associated with the likelihood of CBD usage in generalized
anxiety disorder while controlling for age, gender, education level, and
generalized anxiety disorder scores.
Evaluation of Reliability of the SCT Constructs Using Cronbach’s Alpha
Upon creating the instrument, a panel of seven experts assisted in assessing the
face and content validity of the survey questions. The goal of this procedure was to
minimize threats to internal validity. The individuals who comprised this panel were
high-level experts steeped in various healthcare sectors, including pharmacology, mental
health, health linguistics, public health, and health law (See Appendix B). Confirmatory
factor analysis using maximum likelihood method was run in SPSS for each subscale to
further assess construct validity of the instrument. The Eigenvalue over 1.0, and factor
loadings over 0.48 (succeeding doubling the critical value of 0.24 for the sample size of
114) for each line item were the criteria utilized to confirm the factor structure (Sharma
& Petosa, 2014; Stevens, 1996). All subscales were found to be construct valid.
To assure internal consistency reliability of the purpose-built study instrument, I
conducted a coefficient alpha in SPSS (Tavakol & Dennick, 2011). The Cronbach’s alpha
assessment was used to evaluate each SCT construct operationalized in this study. This
test created a summary of internal consistency and reliability by calculating the
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intercorrelation of the items of the survey design (Santesson et al., 2020; Sharma &
Petosa, 2014). The result of CA is a number between 0 and 1 (Bonett & Wright, 2014).
Except for the construct situational perception, the Cronbach’s alphas were over 0.70 and
thus acceptable. See Table 2 below.

Table 2
CA for SCT Constructs

Construct

Outcome Expectations
Outcome Expectancies
Situational Perception
Self- Efficacy
Goal Setting

Number of Items

5
5
4
4
4

Cronbach’s Alpha

.863
.848
.64
.829
.831

The descriptive statistics of the independent variables- the five constructs of SCTknowledge, outcome expectations/expectancies, situational perception, self-efficacy, and
goal setting, and the dependent variable- the likelihood of CBD usage for GAD are
shown in Table 3 below.
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Table 3
Descriptive Statistics of the Study Variables for RQ1

Likelihood of CBD Use

N
114

Mean
2.59

Std Deviation
1.342

Range
0-04

Knowledge

114

6.59

1.634

1-10

Expectations

114

45.95

20.250

0-80

Situational Perception

114

11.74

2.439

0-16

Self-efficacy

114

10.04

3.771

0-16

Goal Setting

114

9.22

4.378

0-16

Note. Dependent Variable: Likelihood of CBD Use. Predictors: Knowledge,
Expectations, Situational Perception, Self-efficacy, Goalsetting.

The Scoring Range, Mean, and Standard Deviation of the 5 SCT Constructs
The scores of the construct knowledge were determined on a scale of 1-10.
Expectations and expectancies, when multiplied, raise the scoring range to 0-80.
Perception, self-efficacy, and goal setting have a scoring range of 0-16. While the
smallest percentage of participants chose not at all likely to use CBD to decrease
generalized anxiety, the largest percentage of the participant pool revealed highly likely to
use CBD as an aid in minimizing generalized anxiety. The standard deviation result (SD
= 1.342) of the DV denotes a clustering around the mean, proving low variability. With a
scoring range of 0-4, where 0 = no, 1 = probably not, 2 = maybe, 3 = probably, and 4 =
highly likely. An assessment of the analysis assumption boxplot reveals slight skew and
insignificant univariate outliers, as noted in the boxplot in Figure 2 below.
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Figure 2
Boxplot of the Constructs of the Social Cognitive Theory
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Pearson Correlation Statistical Test
I ran a Pearson correlation to evaluate the inclusion of the covariates, including
the five constructs of the SCT- knowledge, outcome expectations, situational perception,
self-efficacy, and goal setting, with the dependent variable- the likelihood of CBD use.
From this dataset, one notes the strongest correlation between goal setting and the
likelihood of CBD use (r = .768, p = 0.00). The next highest correlation exists between
goal setting and expectations (r = .658, p = 0.00). A high correlation also exists between
perception and expectations (r = .594, p = .000). Also highly correlated, the likelihood of
CBD use and expectations (r = .558, p = 0.00), as shown below.
Table 4
Correlation Matrix Table of SCT Constructs with DV Likelihood of Using CBD for GAD
Pearson
Correlation

Likelihood of
CBD Usage

Knowledge

Expectations Perception

Knowledge

.241**

Expectations

.558**

.256*

Perception

.504**

.410**

.594**

Self-Efficacy

.072

.104

.352**

.207

Goal Setting

.768**

.290**

.658**

.531**

SelfEfficacy

.207**

Correlation is significant at the .05 level (1 tailed)*
Correlation is significant at the .01 level (1 tailed)**
Assumptions for this Study
One of the assumptions is that the DV- Likelihood of CBD Usage is a continuous
or interval/ratio variable. The same holds true for the five constructs of the SCT
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constructs. These five constructs- the independent variables, are all measured on a Likert
scale with the assumption that this provides the ability that one can derive from the
instrument a summative score. This assumption on the dependent variable (ratio/interval)
allows for using the multiple linear regression statistical test and is the basis for this
choice of statistical test for this study.
The following summary showcases the amount of variance resulting in the three
predictors- goal setting, self-efficacy, and perception. Statistical significance is seen in
Model 3. Among the participants surveyed (n = 114), R2 = .643, F (3, 110) = 65.903, p ≤
.0001; adjusted R2 = .633. Specifically, Model 3 reveals the statistical significance with
an adjusted R-square result of .663, explaining the variation total in the dependent
variable- the likelihood of CBD use. The adjusted R-squared result of .633 highlights that
combined, these three variables explain 63% of the variance in the dependent variable.
The R-squared represents the proportion of the variance in the dependent variable, while
the adjusted R-squared creates an estimation in the total population under examination
(Miles, 2014), as shown in Table 5 below.

62
Table 5
Step-wise Regression Table
Model

R

R2

Adjusted R2

SE of the
Estimate

1
2
3

.768
.792
.802

.591
.628
.643

.587
.621
.633

.863
.826
.813

1. Predictors: (Constant), Goal Setting
2. Predictors: (Constant), Goal Setting, Self-Efficacy
3. Predictors: (Constant), Goal Setting, Self-Efficacy, Perception
Dependent variable: Likelihood of CBD Use

Next, the regression provided the results of the analysis of the difference in
means. Analyzing the sum of squares, I sought to determine if a statistically significant
difference existed between the means of the three predictor constructs in Model 3. It is
essential to understand that alone, this test does not specify which of the means are
different from each of the other means. However, with the established significance level
of 0.05 (p = .000), we can conclude that there is a statistically significant difference
between goal setting, self-efficacy, and perception. This analysis of the means provides
the ability to examine if there are statistical differences among the means of two groups
or more. This regression output enables the assessor to conclude that the likelihood of
CBD use is significantly different for at least one of the SCT constructs utilized in the
analysis of the difference of the means test. The dependent variable- the likelihood of
CBD usage is significantly different for at least one of the SCT constructs utilized in the
analysis of the difference in means.
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The residual, also known as the errors of the sum of squares, resulted in a total of
72.792. This figure is achieved by determining the difference between the likelihood of
CBD use by subtracting the actual scores from the estimated scores, or vice versa, and
then squaring that sum. These analyses allow the scientist to examine if there are
statistical differences among the means of two groups or more. The regression output
enables the assessor to conclude that likelihood of CBD use is significantly different for
at least one of the SCT constructs utilized to analyze the difference in the means test. The
regression sum of squares and the residual sum of squares equate to the sum of squares.
The subsequent relevant data are an assessment of the analysis of the difference in
means. Here, I determined the difference between the mean of the dependent variable
likelihood of CBD use and the actual value, with a result of 203.623. In the analysis of
the regression sum of squares, the result is 130.831. The analysis of the residual- the
result is 72.792. The residual sum of squares and the regression sum of squares is equal to
the total sum of squares. See Table 6 below.
Table 6
Model 3 ANOVA Summary
Model3

𝑑𝑓

Sum of
Squares

Regression
130.831
3
Residual
72.792
110
Total
203.623
113
Dependent Variable: Likelihood of CBD Use

Mean
Square
43.61
.662
1.802

F

65.903

Predictors: (Constant), Goal Setting, Self-Efficacy, Perception

p

<.0001
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In another statistical test, the coefficients table includes multiple values that
enable analysts to glean a more thorough understanding of the stepwise regression. The
stepwise regression was utilized because all the five predictors did not contribute
uniquely to predicting the dependent variable- the likelihood of CBD use. For this
stepwise regression, there was a removal of the predictors below a threshold of 0.05.
Hence, there are no ‘non-significant’ predictors remaining in the model. In Model 3, we
see the output using the predictors that have contributed most to the outcome variable.
Under the unstandardized coefficients column, the βeta column holds the
regression equation, which follows: The Y-intercept is symbolized by ŷ = the likelihood
of CBD use where the constant value of βo (.256) is added to the value of β1 (.233) and is
then multiplied by the participants’ actual GoalSetting_Sum score. This equation reveals
that those respondents scoring one point higher on goal setting will have an average score
of 0.233 points higher on the dependent variable- the likelihood of CBD use. Next,
adding the β3 estimate value (.079) from the coefficients table then multiplying the
participants’ actual Perception_Sum score in the model will determine the participants’
estimated likelihood of CBD use value. Assessing significance, goal setting (p = .000),
which is less than the established significance level of 0.05, as well as the construct selfefficacy (p = .001), and situational perception (p = .035). In conclusion, all independent
variables in Model 3 show statistical significance in predicting the likelihood of using
CBD for GAD. This section of analysis enabled me to gain a deeper understanding by
analyzing the size of the relation and the direction of the association between the
predictor variable and response variables.
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Research Question 2
Research Question 2: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy in using CBD, and goal setting for the
application of an effective treatment protocol associated with the likelihood of CBD
usage in generalized anxiety disorder, while controlling for age, gender, level of
education, and generalized anxiety disorder scores?
H02: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are not associated with the likelihood of CBD usage in
generalized anxiety disorder while controlling for age, gender, level of education,
and generalized anxiety disorder scores.
Ha2: Knowledge, outcome expectations and expectancies, situational perceptions,
self-efficacy in using CBD, and goal setting for the application of an effective
treatment protocol are associated with the likelihood of CBD usage in generalized
anxiety disorder while controlling for age, gender, education level, and
generalized anxiety disorder scores.
The descriptive statistics output for RQ2 includes the continuous age, revealing
this measurement of central tendency (M = 55.18). The choices for gender included 1 =
female, 2 = male, 3 = LGBTQ, 4 = other, and 5 = prefer not to answer. Here, (M = 1.19),
thus revealing that the sample was predominantly female. In assessing the mean for
education level, with choices including 1 = less than high school, 2 = high school or
equivalent, 3 = some college, but no degree, 4 = associate degree, 5 = bachelor’s degree,
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6 = master’s degree, 7 = Ph.D. or other doctoral degree, and 8 = prefer not to answer,
one can gather from assessing the descriptive statistics table that most of the sample holds
a bachelor’s degree (M = 5.10).
In an assessment of GAD scores, with a potential scoring range of 0-21 (M =
6.65). The correlations output for RQ2 include the controlling variables- age, gender,
level of education, and GAD-7 scores, showcased several of these inverse correlations,
meaning that as there is an increase in the value of one of the variables, the value of the
other variable decreases. See Table 7 below.
Table 7
Descriptive Statistics for the Study Variables for RQ2

Variable

Mean

𝑆𝐷

N

Likelihood of CBD Use
Knowledge
Expectations
Perceptions
Self-Efficacy
Goal Setting
Age
Gender
Education
GAD Score

2.59
6.59
45.95
11.74
10.04
9.22
55.18
1.19
5.10
6.65

1.342
1.634
20.250
2.439
3.771
4.378
13.701
.418
1.097
4.833

114
114
114
114
114
114
114
114
114
114

The model summary table highlights the amount of variance that exists in three of
the predictors. The most relevant statistical significance is seen in Model 3, which
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displays the result of .663 adjusted R-square. This test enabled me to conclude that .633
(or 63.3%) of likelihood CBD use results from three of the SCT constructs.
In Model 3, there are three predictors, including goal setting, self-efficacy, and
perception. The adjusted R-squared result of .633 reveals that the combination of these
three predictor variables explains 63% of the variance in the dependent variable. While
the adjusted R-squared creates an estimation of the population total that is under
examination, the R-Square is a representation of the proportion of the variance in the
dependent variable (Miles, 2014). This statistic enabled me to conclude that .633 of the
variance of the self-reported likelihood of using CBD for GAD was explained by three
predictors, including goal setting, self-efficacy, and perception. The table displays
information about the regression line and the ability of this statistical test to explain the
total variation in the dependent variable- the likelihood of CBD use.
In the final statistical test, the coefficients table provided multiple values that
enabled me to analyze the regression. The output highlights the constructs that have
contributed most significantly to the outcome variable, the likelihood of CBD use. As
noted in the unstandardized coefficients, those study participants who scored one point
higher on the SCT construct- goal setting, will score, on average, 0.233 points higher on
the dependent variable- the likelihood of CBD use. Repeating this process, one notes
significance in goal setting (p = .000), below the established significance level of 0.05.
Self-efficacy (p = .001), and perception (p = .035) both proving to be statistically
significant. In conclusion, all three of the IVs, including goal setting, self-efficacy, and
situational perception, revealed statistical significance and improved prediction of the
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likelihood of using CBD for GAD. In an assessment of the size of the relationship and the
direction of association between the predictor and response variables in Model 3, the
results are in Table 8 below.
Table 8
Regression Coefficients of SCT Constructs on Likelihood of CBD Usage
β

Variable
P

B

(constant)

.256

-.548, 1.060

Goal Setting

.233

.191, .276

Self-Efficacy

-.075

Perception

.079

𝑅 2 = .643,

95%CI

t

p

.632

.529

.761

10.911

.000

-.117, -.032

-.209

-3.464

.001

.006, .152

.144

2.133

.035

Adjusted 𝑅 2 = .633,

𝐹(3, 110) = 65.903, 𝑝 ≤ .0001

Summary
In this chapter, the items relevant to this study and incorporated into the analysis
include descriptive statistics. For analyzing the extent to which each of the quantitatively
measured variables exists in relationship to each other, there was an assessment of the
correlations table for both research questions. To discover pertinent information
regarding the regression line, the model summary provided the ability to glean a deeper
understanding of the total variation of the dependent variable- the likelihood of CBD
usage. The ANOVA summary was analyzed to determine if significant statistical
differences exist between the means of three or more independent variables. The
coefficient table was also included in the analysis- this assessment enabled a deeper
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understanding of the relationship size and direction between predictor and response
variables.
To this end, a summarization of the findings follows: The optimal model remains
the representation found in RQ1. From this dataset, one notes the strongest correlation
between goal setting and the likelihood of CBD use (r = .768, p = 0.00). A high
correlation also exists between perception and expectations (r = .594, p = .000). There
was initially no notable correlation between x and y. However, after using the stepwise
regression method in SPSS, goal setting was selected as a key variable in the model.
Model 3 consisted of goal setting, self-efficacy, and situational perception, as the optimal
model in predicting the self-reported likelihood of using CBD for GAD. These results
enable determining if the gap that brought this study to fruition has been met. A further
examination of the potential limitations of this study and an exploration of potential
further beneficial research follows.
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Chapter 5: Discussion, Conclusions, and Recommendations
The intent of this cross-sectional study was to examine the ability of the five
constructs of the SCT in predicting the self-reported likelihood of CBD usage for GAD. I
also sought to determine if an association existed between the SCT constructs and the
possibility of CBD use while examining if influence resulted from the mediating effects
of age, gender, level of education, and GAD scores. The over-arching goal of this inquiry
was to discover the associations between the SCT constructs and CBD usage and if the
moderating variables impacted the relationship between the constructs and the likelihood
of CBD usage.
In this study, the theoretical framework of SCT aided in discovering if there was
reciprocity between the participant’s environment and certain behavioral factors. The
primary tenet of the SCT is that the subscriber embraces an agentic vantage point to the
behavioral characteristics of self-reflection, proactivity, self-organization, and selfregulation (Bandura, 2005). This study illuminated three SCT constructs, namely goal
setting, self-efficacy, and situational perception, that were significantly associated with
the dependent variable: the likelihood of CBD usage.
Interpretation of the Findings
To my knowledge, there has been no study that has investigated the likelihood of
using CBD for GAD while applying the SCT constructs as a mechanism to predict the
likelihood of usage. However, comprehensive studies have been conducted that applied
SCT to assessing and addressing those social-behavioral perceptions that aid in
identifying nonadherence behaviors (Amico et al., 2018). The positive influence of goal
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setting has also been influential and abundant in other medication protocol-compliance
training (Miller & Bauman, 2014). In this study, goal setting was the construct that
ranked the highest significance in influencing the mechanisms that underlie self-reported
behavioral modulation, thus exhibiting significance in increasing the likelihood of using
CBD for GAD.
The findings in this study showed self-efficacy also contributed to increasing the
likelihood of CBD use for GAD. With a focus on self-efficacy, it is notable that this SCT
construct commonly ranks most substantially in influencing behavioral change
implementation (Bennett et al., 2018). With the recognition that adherence to a
medication protocol remains one of the biggest challenges for healthcare workers and
clinicians, academic studies have provided an understanding that there are three distinct
and quantified stages, including the initiation phase, the act of implementation, and
discontinuation of the protocol (Okuboyejo et al., 2018). Self-efficacy has been strongly
correlated with the adherence to medication regimens in treating HIV and other complex
treatment protocols (Johnson et al., 2007). Okuboyejo et al. (2018) asserted that through
probing into a plethora of instructional innovations that have incorporated self-efficacy, it
is notable that there is a greater likelihood to engage in compliance-building behaviors
when the patient gains the ability to maintain the necessary self-confidence to do so.
Situation perception, an SCT construct that also proved to be significant in this
study, has also been correlated with successful adherence to treatment protocols in
various academic research. One study examined the study participant’s illness perception
as a mechanism to gain a greater understanding of medication protocol adherence,
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utilizing a questionnaire that probed the patient’s perception of the malady of which the
individual has been plagued (Alluhayyan et al., 2020). Dehdari & Dehdari (2019)
conducted a similar study with patients diagnosed with Type 2 diabetes. Their conclusion
was with the recognition that gaining insight into one’s perception of the unique internal
and external situational positions needs consideration when seeking to increase
medication adherence and wellness-supportive therapies (Dehdari & Dehdari, 2019).
Specifically, these researchers pointed to three-pronged situational subthemes:
•

Patient’s comfort level with medication style including consideration of one’s
belief in complementary and alternative medicine versus the allopathic healthcare
model.

•

An examination of one’s confidence in potential treatment effectiveness.

•

Examining the patient on these core issues regarding disease perception aided in
increasing health-supportive behaviors.
Although anyone 18 years of age or older struggling with generalized anxiety was

invited to participate in this study, most respondents were females with a mean age of 55
years. Some research intimates that females are more likely than males to become aware
of their uncontrollable and chronic level of worry (Hantsoo & Epperson 2017). This fact
might aid in understanding why more middle-aged women were quicker to agree to
assess the role that anxiety plays while exercising consideration to explore the likelihood
of taking CBD for potentially diminishing the uncontrollable anxiety levels.
Some of the data collected from the survey questionnaire for the construct
knowledge was particularly notable. The first true or false question: “The Farm Bill of
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2018 determined that CBD was to be extracted from industrial hemp rather than the
marijuana plant.” Eighty respondents (70%) answered: “don’t know.” Eighty-eight of the
respondents (77%) answered false to Question 2: “CBD is not available in a variety of
potencies.” Question 3 explored if “CBD is commonly used to treat generalized anxiety
disorder,” with 90 respondents (78%) answering true.
Question 4 explored if those surveyed believed that “CBD cannot resolve the root
cause of generalized anxiety disorder,” and sixty-nine participants (60%) answered true.
Question 5 examined the sample knowledge of whether “In the United States, more than
40 million adults suffer from a generalized anxiety disorder,” with eighty-seven
respondents (76%) answering true. It is noteworthy that only one respondent (0.008%)
answered false to Question 5.
Ninety-six respondents (84%) recognized that “generalized anxiety is a public
health problem,” as probed in Question 6. Question 7 examined if the “occasional anxiety
is considered normal, while chronic stress is not.” Here, ninety individuals answered true
(78%). Ninety-seven respondents (85%) answered false to Question 8, which examined
the sample’s understanding of the effect of CBD while equating it to that of marijuana“Taking CBD has the same effect as smoking marijuana.” Here, only two respondents
(0.01%) answered true to Question 8. Question 9 probed if “all CBD is sourced from the
same high-quality raw material,” and eighty-eight (77%) answered false. Question 10
was a query into if “CBD can be administered to children,” and 49 respondents (42%)
replied: “don’t know.”
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After handing in the completed questionnaire, some participants quickly explored
the feasibility of taking CBD for generalized anxiety with staff members. It illuminated
that having been enlightened regarding the efficacy of CBD for generalized anxiety, it
was notable that some participants were spurred into action to try CBD even though
many did not initially have prior knowledge of the substance. Some individuals raised the
point of taking CBD while simultaneously applying the SCT behavioral constructs to
increase compliance. This level of interest in CBD and SCT unquestionably resonated
immediately after filling out the survey questionnaire with at least ten respondents,
primarily female. It was particularly noteworthy that one of the respondents reported
back approximately a month after starting a CBD regimen. This individual revealed
having had lifelong struggles with anxiety. Tearfully, this participant thanked us for the
study, admitting that this opportunity had made a life-changing impact. Although
potentially anecdotal, there were several other compelling interactions with participants
who felt the need to convey appreciation for their enlightenment that resulted from the
participation in this study.
Assessing precisely how the findings of this study related to the study problem
and research questions which drove this study, a recapitulation of the research questions,
follows. RQ1 probed: To what extent are knowledge, outcome expectations and
expectancies, situational perceptions, self-efficacy, and goal setting for the application of
an effective treatment protocol associated with the likelihood of CBD usage in
generalized anxiety disorder? RQ2 probed: To what extent are knowledge, outcome
expectations and expectancies, situational perceptions, self-efficacy, and goal setting for
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the application of an effective treatment protocol associated with the likelihood of CBD
usage in generalized anxiety disorder while controlling for age, gender, level of
education, and GAD-7 scores?
A noted gap in the academic literature upon which this study was built addressed
a lack of operational strategies enabling individuals to utilize CBD effectively. Moreover,
another gap existed in the operational design of taking CBD- related explicitly to
discovering solutions through which individuals could determine their effective dosage of
CBD for GAD. I determined that knowledge and outcome expectations and expectancies
were not significant predictors in increasing the likelihood of taking CBD effectively for
GAD. However, in order of significance, goal setting, self-efficacy, and situational
perception proved to be significant predictors of SCT when operationalized to potentially
increase the likelihood of CBD usage.
I determined through this study that the influence of these three constructs- goal
setting, self-efficacy, and situational perception increased an individual’s likelihood of
taking CBD effectively for GAD. Thus, the findings in this study have bridged a
noticeable gap and notable lack in the academic research, which pointed to an absence of
operational strategies in the scientific literature for the likelihood of taking CBD
effectively for GAD. My findings supported that the SCT- the theoretical framework
underlying this study, was instrumental in serving as a functional and effectual
operational tool for this study. These findings can prompt positive social change on the
individual level and the familial and community echelons. As noted in the implications
for practice, these findings can also initiate a positive social change in the realm of
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community public health. Specifically, positive social change is primed through the
dovetailing of the social cognitive theoretical framework with CBD use for GAD.
Limitations of the Study
Self-reporting questionnaires that probe participant’s subjective experience are
not considered the gold standard and are often met with skepticism when compared to,
for example, a face-to-face interview or a videoed interview (Erba et al., 2017). As this
study sought to describe the sample within a population regarding an outcome- the
likelihood of CBD use, a cross-sectional study design was suitable. This design is known
to be beneficial at indicating associations (Levin, 2006). However, the same source points
the potential limitation that stems from the fact that this type of probe occurs at only one
point in time. Also, to minimize time and cost, this study utilized convenience sampling,
which drew volunteers near the research’s place of business. Convenience sampling was
likely the cause that the sample was relatively homogeneous and is a potential limitation
of this study.
Further assessment of potential limitations in this study, it is essential to consider
the study location. This study was conducted in Fairfield County, Connecticut- an
exceptionally high socioeconomic status community. Most of the individuals who
responded to this study have the out-of-pocket expendable income to afford CBD, as it is
a nutraceutical that is not covered by insurance. Therefore, through a lens of social
stratification, if this study were conducted in low socioeconomic status locations
throughout the United States, there would likely be a different outcome in the selfreported likelihood of using CBD for GAD. Likewise, this highly educated community is
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more likely to gain awareness (Dickinson & Adelson, 2014) that anxiety has escalated to
a level that needs treatment and can perhaps begin to manage the disorder before the need
for medical intervention.
Another consideration regarding potential limitations in this study is how
representative the sample is regarding the population of interest and its proportional
representation to the larger population. Although there is a diverse population that shops
and consults at the holistic health center from where the questionnaire was made
available, this study sample was not representative of this fact. Because of the
overrepresentation of White females and those holding at least a bachelor’s degree, this
narrow group creates the potential for issues of a lack of generalizability and external
validity. Also, because shoppers in this SES sector are more likely to be agreeable with
the cost of a high-level quality product, individuals can access quality-controlled CBD
products. Other lower price point CBD formulations often do not yield the same potency
of the active ingredient.
This community is also unique in that individuals have awareness and knowledge
of various brands of CBD made from high-quality raw materials and can quickly and
consistently access those high-quality CBD products. Being located even in nearby
neighborhoods throughout the relatively small state of Connecticut can minimize
accessing high-quality CBD products. These facts could potentially play a role in
diminishing the likelihood of taking CBD for GAD if the participants are not residing in
or around Fairfield County, CT, or another high socioeconomic locale. The data analysis
revealed that the sample was predominately female with a mean age (M = 55.18). Most of
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the sample holds a bachelor’s degree (M = 5.10). This apparent lack of diversity in the
sample introduced a potential threat to external validity.
This study investigated the self-reported likelihood of taking CBD for GAD.
There were five predictor variables: knowledge, outcome expectations and expectancies,
situational perception, self-efficacy in using CBD, and goal setting. The effect size = 0.15
(medium), the alpha level = 0.05, the power = 0.80, and number of predictors 9 (five
constructs of SCT and 4 covariates). Using these indices in G*Power, I determined that a
sample size of 114 participants would confer a medium effect size. However, because
there was a relatively low number of respondents (114), an analysis of subgrouping will
likely not have the power to apply to a broader demographic. This relatively low sample
size could play a role in diminishing the application to a larger population- decreasing
generalizability.
The overrepresentation of female participants increased the potential of
introducing response bias. Assessing another form of response bias, social-desirability
bias, can occur when respondents provide answers to survey questions that they feel
would be favorably viewed by associates and friends (Krumpal, 2013). Although I
conveyed to each participant before filling out the survey that it was of utmost
importance to be blatantly honest with their answers, some might have felt that it was in
their interest to frame CBD positively. Because some of the individuals who filled out the
survey questionnaire are acquainted with me, social-desirability bias could have played a
role in influencing the participants to answer in a manner that would have been deemed
positive by the researcher.
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Recommendations for Further Studies
Undoubtedly, GAD continues to be a growing public health concern, particularly
through the COVID-19 pandemic (Bauerle et al., 2020) that unleashed serendipitously
through the year-long time frame that this dissertation was written. The pandemic has
brought cause for rapid adaptations as conventional medicine has experienced a sharp
increase in prescriptions for benzodiazepines such as Xanax and Klonopin- while
emerging evidence suggests that this class of medication is contraindicated for high-risk
patients with respiratory issues (Ostuzzi et al., 2020). Learning further applications of
CBD for sleep disorders, inflammatory conditions, and seizures disorders through the
lens of SCT could aid this substance to be used safely and ultimately effectively while
perhaps minimizing the common practice of recommending such highly addictive
medications.
Several studies have showcased strong associations between all the SCT
constructs, including knowledge, outcome expectations/expectancies, situational
perception, self-efficacy, and goal setting. However, this study found the three constructs
specifically- goal setting, self-efficacy, and situational perception to be strong predictors
of the dependent variable- the self-reported likelihood of using CBD for GAD. Moreover,
while the sample size was purposefully and precisely calculated for this study, it would
require further academic research to determine if a larger participant pool would prompt a
different outcome. Another consideration is the length of time of the data collection
process. Although many individuals were gracious and committed to participating
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quickly in this study, spreading the collection period over an extended time frame and to
multiple diversified communities appears worthy of another probe.
Implications for Practice
Through the lens of public health, a problem exists in the United States, where 40
million adults are diagnosed with GAD. Still, many individuals are unwilling to take a
prescription medication to treat the condition, and the GAD will go untreated. Some are
hesitant to try CBD even though much research is emerging about its potential benefits
for GAD. This section looks at practical methods to aid practitioners and health educators
in devising effective teaching methods about CBD usage. A review of these findings can
serve to draw implications from the results of this study. The over-arching goal was to
utilize what has been implicated in prompting further inquisitions. The following
information will further operationalize the results obtained in this study, aiding experts in
the field to apply a SCT-based teaching strategy to assist patients in increasing the
likelihood of using CBD for GAD.
Goal Setting in Advising Individuals to Take CBD for GAD
As a potential strategy when taking a medication to aid in minimizing GAD, the
act of goal setting can fortify one’s ability to increase adherence to a CBD protocol. This
study showed that there is a benefit in taking steps that can improve compliance.
Behaviors such a clarifying the intention of taking CBD to decrease GAD and then
committing to taking measures such as daily journaling about the protocol have shown
the promise of significantly increased the likelihood of taking CBD for GAD. For
practical CBD usage, each person was to develop a plan to aid in finding one’s effective
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dosage. This effective dose depends upon the degree of imbalance of the newly
discovered endocannabinoid system (Pertwee, 2006). Raising the patient’s awareness of
goal setting steps such as envisioning what life would be like when no longer paralyzed
with anxiety showed significance in increasing the likelihood of taking CBD for GAD.
Encouraging individuals to create a reward system is beneficial in the goal setting process
when considering implications for practice (Sharma, 2017).
Self-efficacy in Advising Individuals to Take CBD for GAD
Self-efficacy also proved to be a consequential construct of the SCT. Raising
awareness of the importance of increasing one’s confidence in changing the unhealthy
behavior increased the likelihood of taking CBD for GAD. Learning from an expert about
ways to diffuse potential challenges can be liberating- thus minimizing the possible fear
of failure and increasing self-assuredness of complying with a CBD protocol. Aligning
with others in the spirit of a team-building peer support approach has also proven to be
confidence bolstering when creating a new health-building behavior (Bussell, 2017). The
same source asserts that behavioral confidence can be strengthened when hearing from an
important role model such as an expert in the field or even a well-known celebrity touting
a positive experience using CBD for GAD.
Situational Perception in Advising Individuals to Take CBD for GAD
Situational perception is one of the SCT constructs that serves to create a realistic
sense of the circumstances the individual faces when embarking on a behavior. Some
patients struggle and attempt to cope with highly destructive and uncontrollable anxiety
levels, believing that everyone contends with the same dilemma. Having an expert
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convey how life experiences can be when not paralyzed with anxiety can be sobering and
perspective-changing. Exploring one’s awareness, perception, and interpretation can be
the start point to instituting practical steps to increase life skills, coping mechanisms, and
diminishing out-of-control anxiety levels. For example, learning about the abundant
research that has been done on CBD can be fortifying and reassuring. To aid in
relinquishing dosing hesitancy, there is a benefit in guiding the patient to understand that
CBD is a non-mind-altering substance. Modulating an individual’s situational perception
also increased the likelihood of using CBD for generalized anxiety in this study.
Implications for Social Change
This study showcased that disease burden and comorbidities associated with a
GAD could be positively influenced as individuals learn to take CBD more effectively
through the behavioral restructuring brought about by the application of goal setting, selfefficacy, and situational perception- three relevant constructs of SCT. This study
highlighted that the SCT constructs could explain the likelihood of CBD usage for GAD.
One of the values in determining these findings is that these outcomes can be harnessed
to develop a training program that can facilitate taking CBD more effectively for GAD.
Through the lens of public health, this study focused on those who have been
diagnosed with GAD. With further consideration of the numbers of those individuals who
remain undiagnosed with GAD, this study has indicated that there is prudence in creating
tools that enable health educators to teach individuals those metered steps that may
increase the likelihood of taking CBD for GAD. Applying behavioral change techniques
through using the social cognitive theoretical framework indeed showcased positive
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results. Increasing the likelihood of CBD usage can induce positive social change on the
individual level and potentially generate productive revisions in the family structure, the
workplace, and eventually impacting societal transformations.
Conclusions
Generalized anxiety continues to be a public health threat as the number of
individuals diagnosed and undiagnosed with generalized anxiety continues to spike
upward. As a potential solution to this dilemma, this study sought to examine the SCT’s
ability to predict the likelihood of using CBD for GAD. This study highlights the
additional challenges of taking CBD for GAD and the extra responsibility required by
health practitioners to ease individuals into taking CBD for conditions of anxiousness.
While some medical practitioners treating patients with GAD are taking the time to teach
patients about CBD usage, most are not- as this process calls upon a new skill set and
requires more time than is typically allotted. This study determined that three SCT
constructs increased the likelihood of taking CBD for generalized anxiety, including goal
setting, self-efficacy, and situational perception. Hence, the application of the SCT
increased the likelihood of individuals taking CBD- a protocol that is with the possibility
of becoming a viable solution for the treatment of GAD.
We are at a point in history where we are perpetually probing deeper into the
scientific literature and discovering how to create more preventative, safer, efficacious,
and cost-effective treatment protocols. The criterion for this progress was to find
solutions with the most negligible adverse impacts on the human body while increasing
the likelihood of achieving optimal health. Through conducting such inquiries, we are
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learning to prevent the furthering of disease progression, reduce suffering- with an end
goal of teaching patients to become a master of one’s health status. Doing so increases
the individual’s ability to move toward the highest state of optimal health while
minimizing risk and decreasing the level of need for sick-care treatments.
Dovetailing complementary and alternative health treatments within the medical
model is occurring more frequently. As this study considered the increased
implementation of CBD for GAD, there was a discovery that has the potential of
contributing value to the preventative healthcare model. Standardizing these findings into
a SCT-based teaching protocol can create interest for service providers of a practical
implementation that has shown to increase the ease of taking CBD for GAD. On a
grander scale, making inroads that can expose’ the increased likelihood of using CBD for
generalized anxiety in public health initiatives is with the ability to reduce comorbidities
of GAD. Doing so can minimize the need for the eventual more invasive, immoderate,
and cost-prohibitive modalities while aiding the patient to gain a position of authority
over one’s health status. In the spirit of social change in the public’s health, as those
stricken with GAD regain a position of power over one’s health, those friends and family
members who have been impacted will also benefit from the relinquishment of the
disease burden.
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Appendix A: Instrument
Section 1: Knowledge of Cannabidiol (CBD) and Generalized Anxiety Disorder
PLEASE CIRCLE THE ONE ANSWER THAT YOU MOST AGREE WITH
___________________________________________True

False

Don’t Know

1. The Farm Bill of 2018 determined that CBD
is to be extracted from industrial hemp
rather than the marijuana plant.

T

F

?

2. CBD is not available in a variety of potencies.

T

F

?

3. CBD is commonly used to treat
generalized anxiety disorder.

T

F

?

4. CBD cannot resolve the root cause of
generalized anxiety disorder.

T

F

?

5. In the United States, more than 40
million adults suffer from a
generalized anxiety disorder.

T

F

?

6. Generalized anxiety disorder is a public
health problem.

T

F

?

7. While occasional anxiety is considered
normal, chronic stress is not.

T

F

?

8. Taking CBD has the same effect as
smoking marijuana.

T

F

?

9. All CBD is sourced from high-quality material.

T

F

?

10. CBD can be administered to children.

T

F

?

***********************************************************************
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Section 2a: Outcome Expectations
PLEASE CIRCLE THE ONE ANSWER WITH WHICH YOU MOST AGREE
No Probably Not Maybe Probably Highly Likely
11. Taking CBD can
eliminate mild
to severe levels
of anxiety.
12. A benefit of
regular CBD use
is the relief of
inflammation.
13. Many CBD users
experience higher
levels of focus
and concentration
as their anxiety
subsides.
14. Some people no
longer need
anxiety
medication,
because of
taking CBD.
15. Some CBD users
report that close
relations have
noticed they seem
less anxious.

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

****************************************************************
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Section 2b: Outcome Expectancies
PLEASE CIRCLE THE ONE ANSWER WITH WHICH YOU MOST AGREE
Not at all Not Very Somewhat
Very
Important Important Important Important Important
16. It is important
to you that you
eliminate mild
to severe levels
of anxiety.
17. It is important to
you that there
are added benefits
from taking CBDsuch as relief of
inflammation.
18. It is important to
you that, as your
anxiety lessens,
you will have
better focus
and concentration.
19. It is important to
you to stop taking
prescription
medication as
a result of
taking CBD.
20. It is important to
you that close
relations will
witness you being
less anxious.

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

**********************************************************************
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Section 3: Situational Perceptions
PLEASE CIRCLE THE ONE ANSWER WITH WHICH YOU MOST AGREE
No
Probably Maybe Probably
Highly
Not
Likely
21. Abundant research
supports that CBD
is effective for
generalized anxiety
disorder (GAD).
0
1
2
3
4
22. There is adequate
time in my daily
schedule to maintain
a CBD regimen.
0
1
2
3
4
23. Medical doctors
recommend the use
of CBD for GAD.
0
1
2
3
4
24. CBD is a “nonmind-altering”
extract derived from
industrial hemp.
0
1
2
3
4
***************************************************************
Section 4: Self-efficacy in Using CBD
______________________________________________________________________
No
Probably
Maybe Probably
Highly
Not
Likely
25. I would be more
compliant with a CBD
dosing schedule if I
journaled each dose.
0
1
2
3
4
26. Consulting with an
expert on how
to take CBD would
aid in staying steady
with the dosing.
0
1
2
3
4
27. Creating a support
system would help
me to stay motivated
with dosing CBD.
0
1
2
3
4
28. To create a steady habit,
I would find it easier
taking CBD with meals.
0
1
2
3
4
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Section 5: Goal setting
PLEASE CIRCLE ONE ANSWER WITH WHICH YOU MOST AGREE_
No Probably Maybe Probably Highly
Not
Likely_
29. I intend to either begin
using or continue using
CBD for my anxiety.
0
1
2
3
4
30. I am willing to commit
to daily journaling so
that I can notate
how I feel as I adjust
the dosage of CBD.
0
1
2
3
4
31. It is my goal to make
my life more fulfilling
by taking steps to relieve
generalized anxiety
disorder.
0
1
2
3
4
32. I am imagining what
life will be like when
I no longer experience
GAD as a result
of taking CBD.
0
1
2
3
4
*******************************************************************
________________________________________________________________________
Not Probably Maybe Probably
Highly
At All
Not_________
___ ______ Likely___
33. How likely are you
to use CBD to help
decrease your
generalized anxiety
disorder?
0
1
2
3
4

**********************************************************************
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DEMOGRAPHICAL INFORMATION

34. What is your age? ______
o Prefer Not to Answer
35. What is your race/ethnicity?
o
o
o
o
o
o
o
o

White
Black or African American
American Indian or Alaskan Native
Asian
Native Hawaiian or another Pacific Islander
From multiple races
Some other race (Please specify) _________________
Prefer Not to Answer

36. What is your gender identity?
o
o
o
o
o

Female
Male
LGBTQ
Other (Please specify) ___________________
Prefer Not to Answer

37. What is your marital status?
o
o
o
o
o
o

Married
Separated
Divorced
Widowed
Never Married
Prefer Not to Answer
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38. What is the highest level of education you have completed?
o
o
o
o
o
o
o
o

Less than high school
High school or equivalent (e.g., GED)
Some college, but no degree
Associate degree
Bachelor’s degree
Master’s degree
Ph.D. or other Doctoral degrees
Prefer Not to Answer

39. How much total combined income did all members of your household earn
in 2019?
o
o
o
o
o
o

$0 - $9,999
$10,000 - $49,999
$50,000 - $79,999
$80,000 - $99,999
$100,000 or more
Prefer Not to Answer
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Generalized Anxiety Disorder Assessment (GAD-7)
Over the past two weeks, how often have you been bothered by the following:
(A) Feeling nervous, anxious, or on edge?
o Not at all (0)
o Several days (+1)
o More than half the days (+2)
o Nearly every day (+3)
(B) Not being able to stop or control worrying?
o Not at all (0)
o Several days (+1)
o More than half the days (+2)
o Nearly every day (+3)
(C) Worrying too much about different things?
o Not at all (0)
o Several days (+1)
o More than half the days (+2)
o Nearly every day (+3)
(D) Trouble relaxing?
o Not at all (0)
o Several days (+1)
o More than half the days (+2)
o Nearly every day (+3)
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(E) Being so restless that it is hard to sit still?
o Not at all (0)
o Several days (+1)
o More than half the days (+2)
o Nearly every day (+3)
(F) Becoming easily annoyed or irritable?
o Not at all (0)
o Several days (+1)
o More than half the days (+2)
o Nearly every day (+3)
(G) Feeling afraid as if something awful might happen?
o Not at all (0)
o Several days (+1)
o More than half the days (+2)
o Nearly every day (+3)

************************************************************************

Thank You
For Contributing to Positive Social Change!
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Appendix B: Panel of Experts for Assessment of the Instrument Reliability, Content and
Face Validity
Practitioners with Expertise in the Area of Mental Health
Andrew Golden, MA. LPC. LADC, is a Psychotherapist in private practice specializing
in Mood Disorders, Anxiety, and Addiction.

agolden97@earthlink.net

Dr. Wendy Wolfson, a DO/Clinical Psychiatrist, specializes in mood and generalized
anxiety disorders. Dr. Wolfson has breadth and depth of knowledge of pharmaceuticals
and nutraceuticals in the field of mental health.

drwendy@drwendywolfson.com

Practitioners with Expertise in the Area of Instrumentation
Dr. Leslie Elliott was the original Second Committee Member for this dissertation while
also a doctoral student mentor at Walden University. leslie.elliott@mail.waldenu.edu

Dr. Clarence Schumaker, Ph.D., is the Second Committee Member and Approved
Member Methodologist for this dissertation and a doctoral student mentor at Walden
University. clarence.schumaker@mail.waldenu.edu

Dr. Cheryl Greene has a Ph.D. in Rhetoric and Linguistics and has taught in the Program
of Writing and Rhetoric at Stanford University, the University of California Santa Cruz,
and Arizona State University. cherbs.greene@gmail.com

Practitioners with Expertise in the Area of Social Cognitive Theory
Dr. Nina Bell, Ph.D., MPH, Faculty for College of Health, Human Services, and Science
at Ashford University, and Dissertation Mentor at Walden University.
nina.bell@mail.waldenu.edu
Dr. David Duncan, Ph.D., Contributing Faculty Member, School of Health Sciences,
Walden University. david.duncan@mail.waldenu.edu

